Abstract
The process of cellular transformation has been amply studied in vitro using immortalized cell lines. Immortalized cells never have the normal diploid karyotype, nevertheless, they cannot grow over one another in cell culture (contact inhibition), do not form colonies in soft agar (anchorage-dependent growth) and do not form tumors when injected into immunodeficient rodents. All these characteristics can be obtained with additional chromosome changes. Multiple genetic rearrangements, including whole chromosome and gene copy number gains and losses, chromosome translocations, gene mutations are necessary for establishing the malignant cell phenotype. Most of the experiments detecting transforming ability of genes overexpressed and/or mutated in tumors (oncogenes) were performed using mouse embryonic fibroblasts (MEFs), NIH3T3 mouse fibroblast cell line, human embryonic kidney 293 cell line (HEK293), and human mammary epithelial cell lines (mainly HMECs and MCF10A). These cell lines have abnormal karyotypes and are prone to progress to malignantly transformed cells. This review is aimed at understanding the mechanisms of cell immortalization by different “immortalizing agents”, oncogene-induced cell transformation of immortalized cells and moderate response of the advanced tumors to anticancer therapy in the light of tumor “oncogene and chromosome addiction”, intra-/intertumor heterogeneity, and chromosome instability.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kuroki, T. and Huh, N.H., Why Are Human Cells Resistant to Malignant Cell Transformation in vitro? Jpn. J. Cancer Res., 1993, vol. 84, no. 11, pp. 1091–1100.
Malumbres, M. and Barbacid, M., RAS Oncogenes: The First 30 Years, Nat. Rev. Cancer, 2003, vol. 3, no. 6, pp. 459–465.
Stratton, M.R., Exploring the Genomes of Cancer Cells: Progress and Promise, Science, 2011, vol. 331, no. 6024, pp. 1553–1558.
Rangarajan, A. and Weinberg, R.A., Comparative Biology of Mouse Versus Human Cells: Modelling Human Cancer in Mice, Nat. Rev. Cancer, 2003, vol. 3, no. 12, pp. 952–959.
Sherr, C.J. and DePinho, R.A., Cellular Senescence: Mitotic Clock or Culture Shock? Cell, 2000, vol. 102, no. 4, pp. 407–410.
Hahn, W.C. and Weinberg, R.A., Modelling the Molecular Circuitry of Cancer, Nat. Rev. Cancer, 2002, vol. 2, no. 5, pp. 331–341.
Woo, R.A. and Poon, R.Y., Activated Oncogenes Promote and Cooperate with Chromosomal Instability for Neoplastic Transformation, Genes Dev., 2004, vol. 18, no. 11, pp. 1317–1330.
Woo, R.A. and Poon, R.Y., Gene Mutations and Aneuploidy: The Instability That Causes Cancer, Cell Cycle, 2004, vol. 3, no. 9, pp. 1101–1103.
Blasco, M.A., Lee, H.W., Hande, M.P., et al., Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA, Cell, 1997, vol. 91, no. 1, pp. 25–34.
Seger, Y.R., Garcia-Cao, M., Piccinin, S., et al., Transformation of Normal Human Cells in the Absence of Telomerase Activation, Cancer Cell, 2002, vol. 2, no. 5, pp. 401–413.
Soo, J.K., Mackenzie, Ross A.D., Kallenberg, D.M., et al., Malignancy Without Immortality? Cellular Immortalization as a Possible Late Event in Melanoma Progression, Pigment Cell Melanoma Res., 2011, vol. 24, no. 3, pp. 490–503.
Kamijo, T., Zindy, F., Roussel, M.F., et al., Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product P19ARF, Cell, 1997, vol. 91, no. 5, pp. 649–659.
Peeper, D.S., Shvarts, A., Brummelkamp, T., et al., A Functional Screen Identifies HDRIL1 as an Oncogene That Rescues RAS-Induced Senescence, Nat. Cell Biol., 2002, no. 2, pp. 148–153.
Petrenko, O., Zaika, A., and Moll, U.M., DeltaNp73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation in vivo, Mol. Cell. Biol., 2003, vol. 23, no. 16, pp. 5540–5555.
Guo, F. and Zheng, Y., Involvement of Rho Family GTPases in P19Arf- and P53-Mediated Proliferation of Primary Mouse Embryonic Fibroblasts, Mol. Cell. Biol., 2004, vol. 24, no. 3, pp. 1426–1438.
Maeda, T., Hobbs, R.M., Merghoub, T., et al., Role of the Proto-Oncogene Pokemon in Cellular Transformation and ARF Repression, Nature, 2005, vol. 433, no. 7023, pp. 278–285.
Kobayashi, K., Era, T., Takebe, A., et al., ARID3B Induces Malignant Transformation of Mouse Embryonic Fibroblasts and is Strongly Associated With Malignant Neuroblastoma, Cancer Res., 2006, vol. 66, no. 17, pp. 8331–8336.
Sun, H. and Taneja, R., Analysis of Transformation and Tumorigenicity Using Mouse Embryonic Fibroblast Cells, Meth. Mol. Biol., 2007, vol. 383, pp. 303–310.
Ivetac, I., Gurung, R., Hakim, S., et al., Regulation of PI(3)K/Akt Signalling and Cellular Transformation by Inositol Polyphosphate-4-Phosphatase-1, EMBO Rep., 2009, vol. 10, no. 5, pp. 487–493.
Spandidos, D.A. and Wilkie, N.M., Malignant Transformation of Early Passage Rodent Cells by a Single Mutated Human Oncogene, Nature, 1984, vol. 310, no. 5977, pp. 469–475.
Land, H., Chen, A.C., Morgenstern, J.P., et al., Behavior of Myc and Ras Oncogenes in Transformation of Rat Embryo Fibroblasts, Mol. Cell Biol., 1986, vol. 6, no. 6, pp. 1917–1925.
Kelekar, A. and Cole, M.D., Immortalization by c-myc, H-ras, and Ela Oncogenes Induces Differential Cellular Gene Expression and Growth Factor Responses, Mol. Cell. Biol., 1987, vol. 7, no. 11, pp. 3899–3907.
Sugiyama, K., Otori, K., and Esumi, H., Neoplastic Transformation of Rat Colon Epithelial Cells by Expression of Activated Human K-ras, Japan. J. Cancer Res., 1998, vol. 89, no. 6, pp. 615–625.
Zongaro, S., de Stanchina, E., Colombo, T., et al., Stepwise Neoplastic Transformation of a Telomerase Immortalized Fibroblast Cell Line, Cancer Res., 2005, vol. 65, no. 24, pp. 11411–11418.
Boon, E.M., Kovarikova, M., Derksen, P.W., and van der Neut, R., MET Signalling in Primary Colon Epithelial Cells Leads to Increased Transformation Irrespective of Aberrant Wnt Signalling, Brit. J. Cancer, 2005, vol. 92, no. 6, pp. 1078–1083.
Ayyanan, A., Civenni, G., Ciarloni, L., et al., Increased Wnt Signaling Triggers Oncogenic Conversion of Human Breast Epithelial Cells by a Notch-Dependent Mechanism, Proc. Nat. Acad. Sci. U.S.A., 2006, no. 10, pp. 3799–3804.
Thibodeaux, C.A., Liu, X., Disbrow, G.L., et al., Immortalization and Transformation of Human Mammary Epithelial Cells by a Tumor-Derived Myc Mutant, Breast Cancer Res. Treat., 2009, vol. 116, no. 2, pp. 281–294.
Chapman, S., Liu, X., Meyers, C., et al., Human Keratinocytes are Efficiently Immortalized by a Rho Kinase Inhibitor, J. Clin. Invest., 2010, vol. 120, no. 7, pp. 2619–2626.
Hayflick, L., The Limited in vitro Lifetime of Human Diploid Cell Strains, Exp. Cell Res., 1965, vol. 37, pp. 614–636.
Ohtani, N., Mann, D.J., and Hara, E., Cellular Senescence: Its Role in Tumor Suppression and Aging, Cancer Sci., 2009, vol. 100, no. 5, pp. 792–797.
Lleonart, M.E., Artero-Castro, A., and Kondoh, H., Senescence Induction: A Possible Cancer Therapy, Mol. Cancer, 2009, vol. 8, no. 1, p. 3.
Garbe, J.C., Bhattacharya, S., Merchant, B., et al., Molecular Distinctions Between Stasis and Telomere Attrition Senescence Barriers Shown by Long-Term Culture of Normal Human Mammary Epithelial Cells, Cancer Res., 2009, vol. 69, no. 19, pp. 7557–7568.
McDuff, F.K. and Turner, S.D., Jailbreak: Oncogene-Induced Senescence and Its Evasion, Cell Signal., 2011, vol. 23, no. 1, pp. 6–13.
Evans, R.J., Wyllie, F.S., Wynford-Thomas, D., et al., A P53-Dependent, Telomere-Independent Proliferative Life Span Barrier in Human Astrocytes Consistent with the Molecular Genetics of Glioma Development, Cancer Res., 2003, vol. 63, no. 16, pp. 4854–4861.
Fu, B., Quintero, J., and Baker, C.C., Keratinocyte Growth Conditions Modulate Telomerase Expression, Senescence, and Immortalization by Human Papillomavirus Type 16 E6 and E7 Oncogenes, Cancer Res., 2003, vol. 63, no. 22, pp. 7815–7824.
Courtois-Cox, S., Jones, S.L., and Cichowski, K., Many Roads Lead to Oncogene-Induced Senescence, Oncogene, 2008, vol. 27, no. 20, pp. 2801–2809.
Hydbring, P. and Larsson, L.G., Cdk2: A Key Regulator of the Senescence Control Function of Myc, Aging (Albany New York), 2010, Vol. 2, no. 4, pp. 244–250.
Voghel, G., Thorin-Trescases, N., Mamarbachi, A.M., et al., Endogenous Oxidative Stress Prevents Telomerase-Dependent Immortalization of Human Endothelial Cells, Mech. Ageing Dev., 2010, vol. 131, no. 5, pp. 354–363.
Yaswen, P. and Stampfer, M.R., Molecular Changes Accompanying Senescence and Immortalization of Cultured Human Mammary Epithelial Cells, Int. J. Biochem. Cell Biol., 2002, vol. 34, no. 11, pp. 1382–1394.
Evan, G.I., D’Adda Di Fagagna F. Cellular Senescence: Hot or What? Curr. Opin. Genet. Dev., 2009, vol. 19, no. 1, pp. 25–31.
Fridman, A.L. and Tainsky, M.A., Critical Pathways in Cellular Senescence and Immortalization Revealed by Gene Expression Profiling, Oncogene, 2008, vol. 27, no. 46, pp. 5975–5987.
Indran, I.R., Hande, M.P., and Pervaiz, S., Tumor Cell Redox State and Mitochondria at the Center of the Non-Canonical Activity of Telomerase Reverse Transcriptase, Mol. Aspects Med., 2010, vol. 31, no. 1, pp. 21–28.
Kim, D. and Chung, J., Akt: Versatile Mediator of Cell Survival and Beyond, J. Biochem. Mol. Biol., 2002, vol. 35, no. 1, pp. 106–115.
Bitto, A., Sell, C., Crowe, E., et al., Stress-Induced Senescence in Human and Rodent Astrocytes, Exp. Cell Res., 2010, no. 17, pp. 2961–2968.
Heeg, S., Doebele, M., von Werder, A., and Opitz, O.G., In vitro Transformation Models: Modeling Human Cancer, Cell Cycle, 2006, vol. 5, no. 6, pp. 630–634.
Rao, K., Alper, O., Opheim, K.E., et al., Cytogenetic Characterization and H-ras Associated Transformation of Immortalized Human Mammary Epithelial Cells, Cancer Cell Int., 2006, vol. 6, no. 15.
Hong, H.X., Zhang, Y.M., Xu, H., et al., Immortalization of Swine Umbilical Vein Endothelial Cells with Human Telomerase Reverse Transcriptase, Mol. Cells, 2007, vol. 24, no. 3, pp. 358–363.
Cowling, V.H. and Cole, M.D., E-Cadherin Repression Contributes to c-myc-Induced Epithelial Cell Transformation, Oncogene, 2007, vol. 26, no. 24, pp. 3582–3586.
De Filippis, L., Ferrari, D., Rota, Nodari L., et al., Immortalization of Human Neural Stem Cells with the c-myc Mutant T58A, PLoS One, 2008, vol. 3, no. 10, p. e3310.
Abken, H., Butzler, C., and Willecke, K., Immortalization of Human Lymphocytes by Transfection with DNA from Mouse L929 Cytoplasts, Proc. Nat. Acad. Sci. USA, 1988, vol. 85, no. 2, pp. 468–472.
Shay, J.W., Wright, W.E., and Werbin, H., Defining the Molecular Mechanisms of Human Immortalization, Biochim. Biophys. Acta, 1991, vol. 1072, no. 1, pp. 1–7.
Yuan, H., Veldman, T., Rundell, K., and Schlegel, R., Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells, J. Virol., 2002, vol. 76, no. 21, pp. 10685–10691.
Price, T.N., Burke, J.F., and Mayne, L.V., A Novel Human Astrocyte Cell Line (A735) with Astrocyte-Specific Neurotransmitter Function, In Vitro Cell Dev. Biol. Anim., 1999, vol. 35, no. 5, pp. 279–288.
Radna, R.L., Caton, Y., Jha, K.K., et al., Growth of Immortal Simian Virus 40 TsA-Transformed Human Fibroblasts Is Temperature Dependent, Mol. Cell. Biol., 1989, vol. 9, no. 7, pp. 3093–3096.
Shay, J.W. and Wright, W.E., Quantitation of the Frequency of Immortalization of Normal Human Diploid Fibroblasts by SV40 Large T-Antigen, Exp. Cell Res., 1989, vol. 184, no. 1, pp. 109–118.
Wright, W.E., Pereira-Smith, O.M., and Shay, J.W., Reversible Cellular Senescence: Implications for Immortalization of Normal Human Diploid Fibroblasts, Mol. Cell. Biol., 1989, vol. 9, no. 7, pp. 3088–3092.
Coca-Prados, M. and Wax, M.B., Transformation of Human Ciliary Epithelial Cells by Simian Virus 40: Induction of Cell Proliferation and Retention of beta 2-Adrenergic Receptors, Proc. Nat. Acad. Sci. U.S.A., 1986, vol. 83, no. 22, pp. 8754–8758.
Ishida, T., Ando, H., Nomura, S., et al., Establishment and Characterization of Human Fetal Liver Epithelial Cell Line Transfected with SV40 T Antigen, Proc. Soc. Exp. Biol. Med., 1995, vol. 209, no. 3, pp. 251–256.
Chang, S.E., Keen, J., Lane, E.B., and Taylor-Papadimitriou, J., Establishment and Characterization of SV40-Transformed Human Breast Epithelial Cell Lines, Cancer Res., 1982, vol. 42, no. 5, pp. 2040–2053.
Kaighn, M.E., Reddel, R.R., Lechner, J.F., et al., Transformation of Human Neonatal Prostate Epithelial Cells by Strontium Phosphate Transfection with a Plasmid Containing SV40 Early Region Genes, Cancer Res., 1989, no. 11, pp. 3050–3056.
Gruenert, D.C., Basbaum, C.B., Welsh, M.J., et al., Characterization of Human Tracheal Epithelial Cells Transformed by an Origin-Defective Simian Virus 40, Proc. Nat. Acad. Sci. U.S.A., 1988, vol. 85, no. 16, pp. 5951–5955.
Christian, B.J., Loretz, L.J., Oberley, T.D., and Reznikoff, C.A., Characterization of Human Uroepithelial Cells Immortalized in vitro by Simian Virus 40, Cancer Res., 1987, vol. 47, no. 22, pp. 6066–6073.
Woodworth, C.D., Bowden, P.E., Doniger, J., et al., Characterization of Normal Human Exocervical Epithelial Cells Immortalized in vitro by Papillomavirus Types 16 and 18 DNA, Cancer Res., 1988, vol. 48, no. 16, pp. 4620–4628.
Pecoraro, G., Morgan, D., and Defendi, V., Differential Effects of Human Papillomavirus Type 6, 16, and 18 DNAs on Immortalization and Transformation of Human Cervical Epithelial Cells, Proc. Nat. Acad. Sci. U.S.A., 1989, vol. 86, no. 2, pp. 563–567.
Durst, M., Dzarlieva-Petrusevska, R.T., Boukamp, P., et al., Molecular and Cytogenetic Analysis of Immortalized Human Primary Keratinocytes Obtained after Transfection with Human Papillomavirus Type 16 DNA, Oncogene, 1987, vol. 1, no. 3, pp. 251–256.
Pirisi, L., Yasumoto, S., Feller, M., et al., Transformation of Human Fibroblasts and Keratinocytes with Human Papillomavirus Type 16 DNA, J. Virol., 1987, vol. 61, no. 4, pp. 1061–1066.
Munger, K., Werness, B.A., Dyson, N., et al., Complex Formation of Human Papillomavirus E7 Proteins with the Retinoblastoma Tumor Suppressor Gene Product, EMBO J., 1989, vol. 8, no. 13, pp. 4099–4105.
Hudson, J.B., Bedell, M.A., McCance, D.J., and Laiminis, L.A., Immortalization and Altered Differentiation of Human Keratinocytes in vitro by the E6 and E7 Open Reading Frames of Human Papillomavirus Type 18, J. Virol., 1990, vol. 64, no. 2, pp. 519–526.
Zhang, H., Jin, Y., Chen, X., et al., Papillomavirus Type 16 E6/E7 and Human Telomerase Reverse Transcriptase in Esophageal Cell Immortalization and Early Transformation, Cancer Lett., 2007, vol. 245, nos. 1–2, pp. 184–194.
Woodworth, C.D., Doniger, J., and DiPaolo, J.A., Immortalization of Human Foreskin Keratinocytes by Various Human Papillomavirus DNAs Corresponds to Their Association with Cervical Carcinoma, J. Virol., 1989, vol. 63, no. 1, pp. 159–164.
Blanton, R.A., Perez-Reyes, N., Merrick, D.T., and McDougall, J.K., Epithelial Cells Immortalized by Human Papillomaviruses Have Premalignant Characteristics in Organotypic Culture, Am. J. Pathol., 1991, vol. 138, no. 3, pp. 673–685.
Tsutsui, T., Kumakura, S., Yamamoto, A., et al., Association of P16 (INK4a) and PRb Inactivation with Immortalization of Human Cells, Carcinogenesis, 2002, vol. 23, no. 12, pp. 2111–2117.
Halbert, C.L., Demers, G.W., and Galloway, D.A., The E7 Gene of Human Papillomavirus Type 16 Is Sufficient for Immortalization of Human Epithelial Cells, J. Virol., 1991, vol. 65, no. 1, pp. 473–478.
Band, V., Zajchowski, D., Kulesa, V., and Sager, R., Human Papilloma Virus DNAs Immortalize Normal Human Mammary Epithelial Cells and Reduce Their Growth Factor Requirements, Proc. Nat. Acad. Sci. U.S.A., 1990, vol. 87, no. 1, pp. 463–467.
Wazer, D.E., Liu, X.L., Chu, Q., et al., Immortalization of Distinct Human Mammary Epithelial Cell Types by Human Papilloma Virus 16 E6 or E7, Proc. Nat. Acad. Sci. U.S.A., 1995, vol. 92, no. 9, pp. 3687–3691.
Reznikoff, C.A., Belair, C., Savelieva, E., et al., Long-Term Genome Stability and Minimal Genotypic and Phenotypic Alterations in HPV16 E7-, but not E6-Immortalized Human Uroepithelial Cells, Genes Dev., 1994, vol. 8, no. 18, pp. 2227–2240.
Carmean, N., Kosman, J.W., Leaf, E.M., et al., Immortalization of Human Urothelial Cells by Human Papillomavirus Type 16 E6 and E7 Genes in a Defined Serum-Free System, Cell Prolif., 2007, vol. 40, no. 2, pp. 166–184.
Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R., Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, J. Gen. Virol., 1977, vol. 36, no. 1, pp. 59–74.
Reddel, R.R., Ke, Y., Gerwin, B.I., et al., Transformation of Human Bronchial Epithelial Cells by Infection with SV40 or Adenovirus-12 SV40 Hybrid Virus, or Transfection via Strontium Phosphate Coprecipitation with a Plasmid Containing SV40 Early Region Genes, Cancer Res., 1988, vol. 48, no. 7, pp. 1904–1909.
Rhim, J.S., Jay, G., Arnstein, P., et al., Neoplastic Transformation of Human Epidermal Keratinocytes by AD12-SV40 and Kirsten Sarcoma Viruses, Science, 1985, vol. 227, no. 4691, pp. 1250–1252.
Farwell, D.G., Shera, K.A., Koop, J.I., et al., Genetic and Epigenetic Changes in Human Epithelial Cells Immortalized by Telomerase, Am. J. Pathol., 2000, vol. 156, no. 5, pp. 1537–1547.
Tao, Q., Lv, B., Qiao, B., et al., Immortalization of Ameloblastoma Cells via Reactivation of Telomerase Function: Phenotypic and Molecular Characteristics, Oral Oncol., 2009, vol. 45, no. 12, pp. 239–244.
Jiang, X.R., Jimenez, G., Chang, E., et al., Telomerase Expression in Human Somatic Cells Does Not Induce Changes Associated with a Transformed Phenotype, Nat. Genet., 1999, vol. 21, no. 1, pp. 111–114.
Morales, C.P., Holt, S.E., Ouellette, M., et al., Absence of Cancer-Associated Changes in Human Fibroblasts Immortalized with Telomerase, Nat. Genet., 1999, vol. 21, no. 1, pp. 115–118.
Noble, J.R., Zhong, Z.H., Neumann, A.A., et al., Alterations in the P16(INK4a) and P53 Tumor Suppressor Genes of HTERT-Immortalized Human Fibroblasts, Oncogene, 2004, vol. 23, no. 17, pp. 3116–3121.
Dickson, M.A., Hahn, W.C., Ino, Y., et al., Human Keratinocytes That Express HTERT and Also Bypass a P16(INK4a)-Enforced Mechanism That Limits Life Span Become Immortal Yet Retain Normal Growth and Differentiation Characteristics, Mol. Cell. Biol., 2000, vol. 20, no. 4, pp. 1436–1447.
Kim, H., Farris, J., Christman, S.A., et al., Events in the Immortalizing Process of Primary Human Mammary Epithelial Cells by the Catalytic Subunit of Human Telomerase, Biochem. J., 2002, vol. 365, no. 3, pp. 765–772.
Benanti, J.A., Wang, M.L., Myers, H.E., et al., Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-myc, Mol. Cancer Res., 2007, vol. 5, no. 11, pp. 1181–1189.
Gil, J., Kerai, P., Lleonart, M., et al., Immortalization of Primary Human Prostate Epithelial Cells by c-myc, Cancer Res., 2005, vol. 65, no. 6, pp. 2179–2185.
Nonet, G.H., Stampfer, M.R., Chin, K., et al., The ZNF217 Gene Amplified in Breast Cancers Promotes Immortalization of Human Mammary Epithelial Cells, Cancer Res., 2001, vol. 61, no. 4, pp. 1250–1254.
Opitz, O.G., Suliman, Y., Hahn, W.C., et al., Cyclin D1 Overexpression and P53 Inactivation Immortalize Primary Oral Keratinocytes by a Telomerase-Independent Mechanism, J. Clin. Invest., 2001, vol. 108, no. 5, pp. 725–732.
Pipas, J.M., SV40: Cell Transformation and Tumorigenesis, Virology, 2009, vol. 384, no. 2, pp. 294–303.
Levine, A.J., The Common Mechanisms of Transformation by the Small DNA Tumor Viruses: The Inactivation of Tumor Suppressor Gene Products: P53, Virology, 2009, vol. 384, no. 2, pp. 285–293.
Ghittoni, R., Accardi, R., Hasan, U., et al., The Biological Properties of E6 and E7 Oncoproteins from Human Papillomaviruses, Virus Genes, 2010, vol. 40, no. 1, pp. 1–13.
Huschtscha, L.I. and Reddel, R.R., P16(INK4a) and the Control of Cellular Proliferative Life Span, Carcinogenesis, 1999, vol. 20, no. 6, pp. 921–926.
Haga, K., Ohno, S., Yugawa, T., et al., Efficient Immortalization of Primary Human Cells by P16INK4a-Specific Short Hairpin RNA or Bmi-1, Combined with Introduction of hTERT, Cancer Sci., 2007, vol. 98, no. 2, pp. 147–154.
Zhao, Y., Wang, S., Popova, E.Y., et al., Rearrangement of Upstream Sequences of the hTERT Gene during Cellular Immortalization, Genes Chromosomes Cancer, 2009, no. 11, pp. 963–974.
Frisch, S.M. and Mymryk, J.S., Adenovirus-5 E1A: Paradox and Paradigm, Nat. Rev. Mol. Cell. Biol., 2002, vol. 3, no. 6, pp. 441–452.
Cesare, A.J. and Reddel, R.R., Telomere Uncapping and Alternative Lengthening of Telomeres, Mech. Ageing Dev., 2008, vol. 129, nos 1/2, pp. 99–108.
Henson, J.D. and Reddel, R.R., Assaying and Investigating Alternative Lengthening of Telomeres Activity in Human Cells and Cancers, FEBS Lett., 2010, vol. 584, no. 17, pp. 3800–3811.
Adhikary, S. and Eilers, M., Transcriptional Regulation and Transformation by Myc Proteins, Nat. Rev. Mol. Cell. Biol., 2005, vol. 6, no. 8, pp. 635–645.
Yin, X.Y., Grove, L., Datta, N.S., et al., Inverse Regulation of Cyclin B1 by c-myc and P53 and Induction of Tetraploidy by Cyclin B1 Overexpression, Cancer Res., 2001, vol. 61, no. 17, pp. 6487–6493.
Feng, M., Li, Z., Aau, M., et al., Myc/MiR-378/ TOB2/Cyclin D1 Functional Module Regulates Oncogenic Transformation, Oncogene, 2011, vol. 30, no. 19, pp. 2242–2251.
Jung, Y.S., Qian, Y., and Chen, X., Examination of the Expanding Pathways for the Regulation of P21 Expression and Activity, Cell Signal., 2010, vol. 22, no. 7, pp. 1003–1012.
Gartel, A.L., Ye, X., Goufman, E., et al., Myc Represses the P21(WAF1/CIP1) Promoter and Interacts with Sp1/Sp3, Proc. Nat. Acad. Sci. U.S.A., 2001, vol. 98, no. 8, pp. 4510–4515.
Lin, C.P., Liu, C.R., Lee, C.N., et al., Targeting c-myc as a Novel Approach for Hepatocellular Carcinoma, World J. Hepatol., 2010, vol. 2, no. 1, pp. 16–20.
Bartlett, P.F., Reid, H.H., Bailey, K.A., and Bernard, O., Immortalization of Mouse Neural Precursor Cells by the c-myc Oncogene, Proc. Nat. Acad. Sci. U.S.A., 1988, no. 9, pp. 3255–3259.
Gregory, M.A., Qi, Y., and Hann, S.R., The ARF Tumor Suppressor: Keeping Myc on a Leash, Cell Cycle, 2005, vol. 4, no. 2, pp. 249–252.
Dimri, M., Naramura, M., Duan, L., et al., Modeling Breast Cancer-Associated C-Src and EGFR Overexpression in Human MECs: C-Src and EGFR Cooperatively Promote Aberrant Three-Dimensional Acinar Structure and Invasive Behavior, Cancer Res., 2007, no. 9, pp. 4164–4172.
Mills, A.A., Throwing the Cancer Switch: Reciprocal Roles of Polycomb and Trithorax Proteins, Nat. Rev. Cancer, 2010, vol. 10, no. 10, pp. 669–682.
Dimri, G.P., Martinez, J.L., Jacobs, J.J., et al., The Bmi-1 Oncogene Induces Telomerase Activity and Immortalizes Human Mammary Epithelial Cells, Cancer Res., 2002, vol. 62, no. 16, pp. 4736–4745.
Song, L.B., Zeng, M.S., Liao, W.T., et al., Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial Cells, Cancer Res., 2006, vol. 66, no. 12, pp. 6225–6232.
Kim, R.H., Kang, M.K., Shin, K.H., et al., Bmi-1 Cooperates with Human Papillomavirus Type 16 E6 to Immortalize Normal Human Oral Keratinocytes, Exp. Cell Res., 2007, vol. 313, no. 3, pp. 462–72.
Meng, S., Luo, M., Sun, H., et al., Identification and Characterization of Bmi-1-Responding Element within the Human P16 Promoter, J. Biol. Chem., 2010, vol. 285, no. 43, pp. 33219–33229.
Yochum, G.S., McWeeney, S., Rajaraman, V., et al., Serial Analysis of Chromatin Occupancy Identifies beta-Catenin Target Genes in Colorectal Carcinoma Cells, Proc. Nat. Acad. Sci. USA, 2007, vol. 104, no. 9, pp. 3324–3329.
Mosimann, C., Hausmann, G., and Basler, K., beta-Catenin Hits Chromatin: Regulation of Wnt Target Gene Activation, Nat. Rev. Mol. Cell Biol., 2009, vol. 10, no. 4, pp. 276–286.
Delmas, V., Beermann, F., Martinozzi, S., et al., Catenin Induces Immortalization of Melanocytes by Suppressing P16INK4a Expression and Cooperates with N-ras in Melanoma Development, Genes Dev., 2007, vol. 21, no. 22, pp. 2923–2935.
Kim, J., Lee, J.H., and Iyer, V.R., Global Identification of myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In vivo, PLoS ONE, 2008, vol. 3, no. 3, p. e1798.
Krig, S.R., Jin, V.X., Bieda, M.C., et al., Identification of Genes Directly Regulated by the Oncogene ZNF217 Using Chromatin Immunoprecipitation (ChIP)-Chip Assays, J. Biol. Chem., 2007, vol. 282, no. 13, pp. 9703–9712.
Zeller, K.I., Zhao, X., Lee, C.W., et al., Global Mapping of c-myc Binding Sites and Target Gene Networks in Human B Cells, Proc. Nat. Acad. Sci. U.S.A., 2006, vol. 103, no. 47, pp. 17834–17839.
Lawlor, E.R., Soucek, L., Brown-Swigart, L., et al., Reversible Kinetic Analysis of myc Targets in vivo Provides Novel Insights into myc-Mediated Tumorigenesis, Cancer Res., 2006, vol. 66, no. 9, pp. 4591–4601.
Wu, C.H., Sahoo, D., Arvanitis, C., et al., Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC to Maintain Tumorigenesis, PLoS Genet, 2008, vol. 4, no. 6, p. e1000090.
Menssen, A. and Hermeking, H., Characterization of the C-MYC-Regulated Transcriptome by SAGE: Identification and Analysis of C-MYC Target Genes, Proc. Nat. Acad. Sci. U.S.A., 2002, vol. 99, no. 9, pp. 6274–6279.
Connell, B.C., Cheung, A.F., Simkevich, C.P., et al., A Large Scale Genetic Analysis of c-myc-Regulated Gene Expression Patterns, J. Biol. Chem., 2003, vol. 278, no. 14, pp. 12563–12573.
Rea, M.A., Zhou, L., Qin, Q., et al., Spontaneous Immortalization of Human Epidermal Cells with Naturally Elevated Telomerase, J. Invest. Dermatol., 2006, vol. 126, no. 11, pp. 2507–2515.
Brandl, C., Kaesbauer, J., Weber, B.H., and Morsczeck, C., Spontaneous Immortalization of Neural Crest-Derived Corneal Progenitor Cells after Chromosomal Aberration, Cell Prolif., 2010, vol. 43, no. 4, pp. 372–377.
Zhao, C., Meng, L., Hu, H., et al., Spontaneously Immortalised Bovine Mammary Epithelial Cells Exhibit a Distinct Gene Expression Pattern from the Breast Cancer Cells, BMC Cell Biol., 2010, vol. 11, no. 82.
Ohtani, N., Yamakoshi, K., Takahashi, A., and Hara, E., Real-Time in vivo Imaging of P16 Gene Expression: A New Approach to Study Senescence Stress Signaling in Living Animals, Cell Div., 2010, vol. 5, no. 1.
Novak, P., Jensen, T.J., Garbe, J.C., et al., Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization, Cancer Res., 2009, vol. 69, no. 12, pp. 5251–5258.
Darbro, B.W., Lee, K.M., Nguyen, N.K., et al., Methylation of the P16(INK4a) Promoter Region in Telomerase Immortalized Human Keratinocytes Cocultured with Feeder Cells, Oncogene, 2006, vol. 25, no. 56, pp. 7421–7433.
Hinshelwood, R.A., Melki, J.R., Huschtscha, L.I., et al., Aberrant de novo Methylation of the P16INK4A CpG Island Is Initiated Post Gene Silencing in Association with Chromatin Remodelling and Mimics Nucleosome Positioning, Hum. Mol. Genet., 2009, no. 16, pp. 3098–3109.
Agherbi, H., Gaussmann-Wengerm A., Verthuy, C., et al., Polycomb Mediated Epigenetic Silencing and Replication Timing at the INK4a/ARF Locus during Senescence, PLoS One, 2009, vol. 4, no. 5, p. e5622.
Maertens, G.N., El Messaoudi-Aubert, S., Racek, T., et al., Several Distinct Polycomb Complexes Regulate and Co-Localize on the INK4a Tumor Suppressor Locus, PLoS One, 2009, vol. 4, no. 7, p. e6380.
Agger, K., Cloos, P.A., Rudkjaer, L., et al., The H3K27me3 Demethylase JMJD3 Contributes to the Activation of the INK4A-ARF Locus in Response to Oncogene- and Stress-Induced Senescence, Genes Dev., 2009, vol. 23, no. 10, pp. 1171–1176.
Maertens, G.N., El Messaoudi-Aubert, S., Elderkin, S., et al., Ubiquitin-Specific Proteases 7 and 11 Modulate Polycomb Regulation of the INK4a Tumour Suppressor, EMBO J., 2010, vol. 29, no. 15, pp. 2553–2565.
Negishi, M., Saraya, A., Mochizuki, S., et al., A Novel Zinc Finger Protein Zfp277 Mediates Transcriptional Repression of the Ink4a/Arf Locus through Polycomb Repressive Complex 1, PLoS One, 2010, vol. 5, no. 8, p. e12373.
Meng, L., Gabai, V.L., and Sherman, M.Y., Heat-Shock Transcription Factor HSF1 Has a Critical Role in Human Epidermal Growth Factor Receptor-2-Induced Cellular Transformation and Tumorigenesis, Oncogene, 2010, vol. 29, no. 37, pp. 5204–5213.
Romagosa, C., Simonetti, S., Lopez-Vicente, L., et al., P16(Ink4a) Overexpression in Cancer: A Tumor Suppressor Gene Associated with Senescence and High-Grade Tumors, Oncogene, 2011, vol. 30, no. 18, pp. 2087–2097.
Odell, A., Askham, J., Whibley, C., and Hollstein, M., How to Become Immortal: Let MEFs Count the Ways, Aging (Albany New York), 2010, vol. 2, no. 3, pp. 160–165.
Mondello, C., Chiesa, M., Rebuzzini, P., et al., Karyotype Instability and Anchorage-Independent Growth in Telomerase-Immortalized Fibroblasts from Two Centenarian Individuals, Biochem. Biophys. Res. Commun., 2003, vol. 308, no. 4, pp. 914–921.
Milyavsky, M., Shats, I., Erez, N., et al., Prolonged Culture of Telomerase-Immortalized Human Fibroblasts Leads to a Premalignant Phenotype, Cancer Res., 2003, vol. 63, no. 21, pp. 7147–7157.
Pirzio, L.M., Freulet-Marriere, M.A., Bai, Y., et al., Human Fibroblasts Expressing HTERT Show Remarkable Karyotype Stability Even after Exposure to Ionizing Radiation, Cytogenet. Genome Res., 2004, vol. 104, nos 1–4, pp. 87–94.
Cui, W., Aslam, S., Fletcher, J., et al., Stabilization of Telomere Length and Karyotypic Stability Are Directly Correlated with the Level of hTERT Gene Expression in Primary Fibroblasts, J. Biol. Chem., 2002, vol. 277, no. 41, pp. 38531–38539.
Wen, V.W., Wu, K., Baksh, S., et al., Telomere-Driven Karyotypic Complexity Concurs with P16INK4a Inactivation in TP53-Competent Immortal Endothelial Cells, Cancer Res., 2006, vol. 66, no. 22, pp. 10691–10700.
Piao, C.Q., Liu, L., Zhao, Y.L., et al., Immortalization of Human Small Airway Epithelial Cells by Ectopic Expression of Telomerase, Carcinogenesis, 2005, vol. 26, no. 4, pp. 725–731.
Varella-Garcia, M., Chen, L., Zheng, X., et al., Karyotypic Characteristics of Human Uterine Leiomyoma and Myometrial Cell Lines Following Telomerase Induction, Cancer Genet. Cytogenet., 2006, vol. 170, no. 1, pp. 71–75.
Takeuchi, M., Takeuchi, K., Kohara, A., et al., Chromosomal Instability in Human Mesenchymal Stem Cells Immortalized with Human Papilloma Virus E6, E7, and hTERT Genes, In Vitro Cell. Dev. Biol. Anim., 2007, vol. 43, nos 3/4, pp. 129–138.
Haker, B., Fuchs, S., Dierlamm, J., et al., Absence of Oncogenic Transformation Despite Acquisition of Cytogenetic Aberrations in Long-Term Cultured Telomerase-Immortalized Human Fetal Hepatocytes, Cancer Lett., 2007, vol. 256, no. 1, pp. 120–127.
Liu, S., Hatton, M.P., Khandelwal, P., and Sullivan, D.A., Culture, Immortalization, and Characterization of Human Meibomian Gland Epithelial Cells, Invest. Ophthalmol. Vis. Sci., 2010, vol. 51, no. 8, pp. 3993–4005.
Watts, P. Stuart, B., et al., Studies on the Phenotype and Karyotype of Immortalized Rabbit Kidney Epithelial Cell Lines, Exp. Cell Res., vol. 1991, no. 2, pp. 458–461.
Yamasaki, K., Kawasaki, S., Young, R.D., et al., Genomic Aberrations and Cellular Heterogeneity in SV40-Immortalized Human Corneal Epithelial Cells, Invest. Ophthalmol. Vis. Sci., 2009, vol. 50, no. 2, pp. 604–613.
Kubo, C., Tsutsui, T.W., Tamura, Y., et al., Immortalization of Normal Human Gingival Keratinocytes and Cytological and Cytogenetic Characterization of the Cells, Odontology, 2009, vol. 97, no. 1, pp. 18–31.
Tsao, S.W., Wang, X., Liu, Y., et al., Establishment of Two Immortalized Nasopharyngeal Epithelial Cell Lines Using SV40 Large T and HPV16 E6/E7 Viral Oncogenes, Biochim. Biophys. Acta, 2002, vol. 1590, nos. 1–3, pp. 150–158.
Schiller, J.H., Bittner, G., Wu, S.Q., and Meisner, L., Karyotypic Changes Associated with Spontaneous Acquisition and Loss of Tumorigenicity in a Human Transformed Bronchial Epithelial Cell Line: Evidence for in vivo Selection of Transformed Clones, In vitro Cell Dev. Biol. Anim, 1998, vol. 34, no. 4, pp. 283–289.
Toouli, C.D., Huschtscha, L.I., Neumann, A.A., et al., Comparison of Human Mammary Epithelial Cells Immortalized by Simian Virus 40 T-Antigen or by the Telomerase Catalytic Subunit, Oncogene, 2002, vol. 21, no. 1, pp. 128–139.
Hashida, T. and Yasumoto, S., Induction of Chromosome Abnormalities in Mouse and Human Epidermal Keratinocytes by the Human Papillomavirus Type 16 E7 Oncogene, J. Gen. Virol., 1991, vol. 72, no. 7, pp. 1569–1577.
Bonin, L.R., Madden, K., Shera, K., et al., Generation and Characterization of Human Smooth Muscle Cell Lines Derived from Atherosclerotic Plaque, Arterioscler., Thromb. Vasc. Biol., 1999, vol. 19, no. 3, pp. 575–587.
Jin, Y., Feng, H.C., Deng, W., et al., Immortalization of Human Extravillous Cytotrophoblasts by Human Papilloma Virus Gene E6/E7: Sequential Cytogenetic and Molecular Genetic Characterization, Cancer Genet. Cytogenet., 2005, vol. 163, no. 1, pp. 30–37.
Ramirez, R.D., Sheridan, S., Girard, L., et al., Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins, Cancer Res., 2004, vol. 64, no. 24, pp. 9027–9034.
Todaro, G.J. and Green, H., Quantitative Studies of the Growth of Mouse Embryo Cells in Culture and Their Development into Established Lines, J. Cell Biol., 1963, no. 17, pp. 299–313.
Endo, S., Metzler, M., and Hieber, L., Nonrandom Karyotypic Changes in a Spontaneously Immortalized and Tumorigenic Syrian Hamster Embryo Cell Line, Carcinogenesis, 1994, vol. 15, no. 10, pp. 2387–2390.
Allen-Hoffmann, B.L., Schlosser, S.J., Ivarie, C.A., et al., Normal Growth and Differentiation in a Spontaneously Immortalized Near-Diploid Human Keratinocyte Cell Line, NIKS, J. Invest. Dermatol., 2000, vol. 114, no. 3, pp. 444–455.
Grinchuk, T.M., Pugovkina, N.A., Tarunina, M.V., et al., Immortalized Cell Lines from Murine Embryos Are Characterized by Progressive Destabilization of Their Karyotype Structure, Tsitologiia, 2004, vol. 46, no. 1, pp. 62–68.
Fulcher, M.L., Gabriel, S.E., Olsen, J.C., et al., Novel Human Bronchial Epithelial Cell Lines for Cystic Fibrosis Research, Amer. J. Physiol. Lung Cell Mol. Physiol., 2009, vol. 296, no. 1, pp. 82–91.
Marella, N.V., Malyavantham, K.S., Wang, J., et al., Cytogenetic and cDNA Microarray Expression Analysis of MCF10 Human Breast Cancer Progression Cell Lines, Cancer Res., 2009, vol. 69, no. 14, pp. 5946–5953.
Fridman, A.L., Tang, L., Kulaeva, O.I., et al., Expression Profiling Identifies Three Pathways Altered in Cellular Immortalization: Interferon, Cell Cycle, and Cytoskeleton, J. Gerontol. A Biol. Sci. Med. Sci., 2006, vol. 61, no. 9, pp. 879–889.
Nakamura, H., Fukami, H., Hayashi, Y., et al., Establishment of Immortal Normal and Ataxia Telangiectasia Fibroblast Cell Lines by Introduction of the hTERT Gene, J. Radiat. Res. (Tokyo), 2002, vol. 43, no. 2, pp. 167–174.
Cui, W., Wylie, D., Aslam, S., et al., Telomerase-Immortalized Sheep Fibroblasts Can Be Reprogrammed by Nuclear Transfer to Undergo Early Development, Biol. Reprod., 2003, vol. 69, no. 1, pp. 15–21.
Krikun, G., Mor, G., Huang, J., et al., Metalloproteinase Expression by Control and Telomerase Immortalized Human Endometrial Endothelial Cells, Histol. Histopathol., 2005, vol. 20, no. 3, pp. 719–724.
Zhang, H., Wang, Y., Zhao, Y., et al., Immortalized Human Neural Progenitor Cells from the Ventral Telencephalon with the Potential to Differentiate into GABAergic Neurons, J. Neurosci. Res., 2008, vol. 86, no. 6, pp. 1217–1226.
Steele, S.L., Wu, Y., Kolb, R.J., et al., Telomerase Immortalization of Principal Cells from Mouse Collecting Duct, Amer. J. Physiol. Renal. Physiol., 2010, vol. 299, no. 6, pp. 1507–1514.
Unger, C., Gao, S., Cohen, M., et al., Immortalized Human Skin Fibroblast Feeder Cells Support Growth and Maintenance of Both Human Embryonic and Induced Pluripotent Stem Cells, Hum. Reprod., 2009, vol. 24, no. 10, pp. 2567–2581.
Donehower, L.A. and Lozano, G., 20 Years Studying P53 Functions in Genetically Engineered Mice, Nat. Rev. Cancer, 2009, vol. 9, no. 11, pp. 831–841.
Li, M., Fang, X., Baker, D.J., et al., The ATM-P53 Pathway Suppresses Aneuploidy-Induced Tumorigenesis, Proc. Nat. Acad. Sci. U.S.A., 2010, vol. 107, no. 32, pp. 14188–14193.
Weiss, M.B., Vitolo, M.I., Mohseni, M., et al., Deletion of P53 in Human Mammary Epithelial Cells Causes Chromosomal Instability and Altered Therapeutic Response, Oncogene, 2010, vol. 29, no. 33, pp. 4715–4724.
Thompson, S.L. and Compton, D.A., Proliferation of Aneuploid Human Cells Is Limited by a P53-Dependent Mechanism, J. Cell Biol., 2010, vol. 188, no. 3, pp. 369–381.
Zhao, T. and Xu, Y., P53 and Stem Cells: New Developments and New Concerns, Trends Cell. Biol., 2010, vol. 20, no. 3, pp. 170–175.
Fukasawa, K., P53, Cyclin-Dependent Kinase and Abnormal Amplification of Centrosomes, Biochim. Biophys. Acta, 2008, vol. 1786, no. 1, pp. 15–23.
Yun, U.J., Park, H.D., and Shin, D.Y., P53 Prevents Immature Escaping from Cell Cycle G2 Checkpoint Arrest Through Inhibiting Cdk2-Dependent NF-Y Phosphorylation, Cancer Res. Treat., 2006, vol. 38, no. 4, pp. 224–228.
Iovino, F., Lentini, L., Amato, A., and Di Leonardo, A., RB Acute Loss Induces Centrosome Amplification and Aneuploidy in Murine Primary Fibroblasts, Mol. Cancer, 2006, vol. 5, no. 38.
Manning, A.L., Longworth, M.S., and Dyson, N.J., Loss of PRB Causes Centromere Dysfunction and Chromosomal Instability, Genes Dev., 2010, vol. 24, no. 13, pp. 1364–1376.
Thompson, S.L., Bakhoum, S.F., and Compton, D.A., Mechanisms of Chromosomal Instability, Curr. Biol., 2010, vol. 20, no. 6, pp. 285–295.
Knudsen, E.S. and Knudsen, K.E., Tailoring to RB: Tumour Suppressor Status and Therapeutic Response, Nat. Rev. Cancer, 2008, vol. 8, no. 9, pp. 714–724.
Hernando, E., Nahle, Z., Juan, G., et al., Rb Inactivation Promotes Genomic Instability by Uncoupling Cell Cycle Progression from Mitotic Control, Nature, 2004, vol. 430, no. 7001, pp. 797–802.
Amato, A., Lentini, L., Schillaci, T., et al., RNAi Mediated Acute Depletion of Retinoblastoma Protein (PRb) Promotes Aneuploidy in Human Primary Cells via Micronuclei Formation, BMC Cell. Biol., 2009, vol. 10, no. 79.
Amato, A., Schillaci, T., Lentini, L., and Di Leonardo, A., CENPA Overexpression Promotes Genome Instability in PRb-Depleted Human Cells, Mol. Cancer, 2009, vol. 8, no. 119.
Srinivasan, S.V., Mayhew, C.N., Schwemberger, S., et al., RB Loss Promotes Aberrant Ploidy by Deregulating Levels and Activity of DNA Replication Factors, J. Biol. Chem., 2007, vol. 282, no. 33, pp. 23867–23877.
Bourgo, R.J., Ehmer, U., Sage, J., and Knudsen, E.S., RB Deletion Disrupts Coordination between DNA Replication Licensing and Mitotic Entry in vivo, Mol. Biol. Cell, 2011, vol. 22, no. 7, pp. 931–939.
Coschi, C.H., Martens, A.L., Ritchie, K., et al., Mitotic Chromosome Condensation Mediated by the Retinoblastoma Protein Is Tumor-Suppressive, Genes Dev., 2010, vol. 24, no. 13, pp. 1351–1363.
Wirt, S.E. and Sage, J., P107 in the Public Eye: An Rb Understudy and More, Cell Div., 2010, vol. 5, no. 9.
Weinberg, R.A., Cell the Retinoblastoma Protein and Cell Cycle Control, Cell, 1995, vol. 81, no. 3, pp. 323–330.
Dannenberg, J.H., Schuijff, L., Dekker, M., et al., Tissuespecific Tumor Suppressor Activity of Retinoblastoma Gene Homologs P107 and P130, Genes Dev., 2004, vol. 18, no. 23, pp. 2952–2962.
Dannenberg, J.H. and te Riele, H.P., The Retinoblastoma Gene Family in Cell Cycle Regulation and Suppression of Tumorigenesis, Results Probl. Cell Differ., 2006, vol. 42, pp. 183–225.
Schaffer, B.E., Park, K.S., Yiu, G., et al., Loss of P130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma, Cancer Res., 2010, vol. 70, no. 10, pp. 3877–3883.
Albertson, D.G., Collins, C., McCormick, F., and Gray, J.W., Chromosome Aberrations in Solid Tumors, Nat. Genet., 2003, vol. 34, no. 4, pp. 369–376.
Hanahan, D. and Weinberg, R.A., Hallmarks of Cancer: The Next Generation, Cell, 2011, vol. 144, no. 5, pp. 646–674.
Santarius, T., Shipley, J., Brewer, D., et al., A Census of Amplified and Overexpressed Human Cancer Genes, Nat. Rev. Cancer, 2010, vol. 10, no. 1, pp. 59–64.
Stratton, M.R., Campbell, P.J., and Futreal, P.A., The Cancer Genome, Nature, 2009, vol. 458, no. 7239, pp. 719–724.
Dai, B., Pieper, R.O., Li, D., et al., FoxM1B Regulates NEDD4-1 Expression, Leading to Cellular Transformation and Full Malignant Phenotype in Immortalized Human Astrocytes, Cancer Res., 2010, vol. 70, no. 7, pp. 2951–2961.
Zhang, X., Yu, C., Wilson, K., et al., Malignant Transformation of Non-Neoplastic Barrett’s Epithelial Cells Through Well-Defined Genetic Manipulations, PLoS One, 2010, vol. 5, no. 9, p. e13093.
Zhu, Y., Zhong, X., Zheng, S., et al., Transformation of Immortalized Colorectal Crypt Cells by Microcystin Involving Constitutive Activation of Akt and MAPK Cascade, Carcinogenesis, 2005, vol. 26, no. 7, pp. 1207–1214.
Narko, K., Ristimaki, A., MacPhee, M., et al., Tumorigenic Transformation of Immortalized ECV Endothelial Cells by Cyclooxygenase-1 Overexpression, J. Biol. Chem., 1997, vol. 272, no. 34, pp. 21455–21460.
Shen, Z.Y., Xu, L.Y., Chen, M.H., et al., Progressive Transformation of Immortalized Esophageal Epithelial Cells, World J. Gastroenterol., 2002, vol. 8, no. 6, pp. 976–981.
Cheng, J.D., Dunbrack, R.L.Jr., Valianou, M., et al., Promotion of Tumor Growth by Murine Fibroblast Activation Protein, a Serine Protease, in an Animal Model, Cancer Res., 2002, vol. 62, no. 16, pp. 4767–4772.
Hamid, T., Malik, M.T., and Kakar, S.S., Ectopic Expression of PTTG1/Securin Promotes Tumorigenesis in Human Embryonic Kidney Cells, Mol. Cancer, 2005, vol. 4, no. 3.
Li, A., Zhang, X.S., Jiang, J.H., et al., Transcriptional Expression of RPMS1 in Nasopharyngeal Carcinoma and Its Oncogenic Potential, Cell Cycle, 2005, vol. 4, no. 2, pp. 304–309.
Castiglioni, F., Tagliabue, E., Campiglio, M., et al., Role of Exon-16-Deleted HER2 in Breast Carcinomas, Endocr. Relat. Cancer, 2006, vol. 13, no. 1, pp. 221–232.
Wang, Y.L., Wang, Y., Tong, L., and Wei, Q., Overexpression of Calcineurin B Subunit (CnB) Enhances the Oncogenic Potential of HEK293 Cells, Cancer Sci., 2008, vol. 99, no. 6, pp. 1100–1108.
Mineur, P., Colige, A.C., Deroanne, C.F., et al., Newly Identified Biologically Active and Proteolysis-Resistant VEGF-A Isoform VEGF111 Is Induced by Genotoxic Agents, J. Cell Biol., 2007, vol. 179, no. 6, pp. 1261–1273.
Chao, C., Goluszko, E., Lee, Y.T., et al., Constitutively Active CCK2 Receptor Splice Variant Increases Src-Dependent HIF-1 alpha Expression and Tumor Growth, Oncogene, 2007, vol. 26, no. 7, pp. 1013–1019.
Depontieu, F., Grigoriu, B.D., Scherpereel, A., et al., Loss of Endocan Tumorigenic Properties after Alternative Splicing of Exon 2, BMC Cancer, 2008, vol. 8, no. 14.
Liu, Y.H., Lin, C.Y., Lin, W.C., et al., Up-Regulation of Vascular Endothelial Growth Factor-D Expression in Clear Cell Renal Cell Carcinoma by CD74: A Critical Role in Cancer Cell Tumorigenesis, J. Immunol, 2008, vol. 181, no. 9, pp. 6584–6594.
Ha, S.A., Kim, H.K., Yoo, J., et al., Transdifferentiationinducing HCCR-1 Oncogene, BMC Cell. Biol., 2010, vol. 11, no. 49.
Jin, G., Kawsar, H.I., Hirsch, S.A., et al., an Antimicrobial Peptide Regulates Tumor-Associated Macrophage Trafficking via the Chemokine Receptor CCR2, a Model for Tumorigenesis, PLoS One, 2010, vol. 5, no. 6.
Liu, S.H., Patel, S., Gingras, M.C., et al., PDX-1: Demonstration of Oncogenic Properties in Pancreatic Cancer, Cancer, 2011, vol. 117, no. 4, pp. 723–733.
Zhou, W.J., Geng, Z.H., Chi, S., et al., Slit-Robo Signaling Induces Malignant Transformation Through Hakai-Mediated E-Cadherin Degradation during Colorectal Epithelial Cell Carcinogenesis, Cell Res., 2011, vol. 21, no. 4, pp. 609–626.
Zhao, J.J., Gjoerup, O.V., Subramanian, R.R., et al., Human Mammary Epithelial Cell Transformation Through the Activation of Phosphatidylinositol 3-Kinase, Cancer Cell, 2003, vol. 3, no. 5, pp. 483–495.
Zelinski, D.P., Zantek, N.D., Stewart, J.C., et al., EphA2 Overexpression Causes Tumorigenesis of Mammary Epithelial Cells, Cancer Res., 2001, vol. 61, no. 5, pp. 2301–2306.
Prescott, J.D., Koto, K.S., Singh, M., and Gutierrez-Hartmann, A., The ETS Transcription Factor ESE-1 Transforms MCF-12A Human Mammary Epithelial Cells via a Novel Cytoplasmic Mechanism, Mol. Cell. Biol., 2004, vol. 24, no. 12, pp. 5548–5564.
Moyano, J.V., Evans, J.R., Chen, F., et al., AlphaB-Crystallin Is a Novel Oncoprotein That Predicts Poor Clinical Outcome in Breast Cancer, J. Clin. Invest., 2006, vol. 116, no. 1, pp. 261–270.
Kim, H.J., Litzenburger, B.C., Cui, X., et al., Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-KappaB and Snail, Mol. Cell. Biol., 2007, vol. 27, no. 8, pp. 3165–3175.
Zhu, T., Starling-Emerald, B., Zhang, X., et al., Oncogenic Transformation of Human Mammary Epithelial Cells by Autocrine Human Growth Hormone, Cancer Res., 2005, vol. 65, no. 1, pp. 317–24.
Mohankumar, K.M., Perry, J.K., Kannan, N., et al., Transcriptional Activation of Signal Transducer and Activator of Transcription (STAT) 3 and STAT5B Partially Mediate Homeobox A1-Stimulated Oncogenic Transformation of the Immortalized Human Mammary Epithelial Cell, Endocrinology, 2008, vol. 149, no. 5, pp. 2219–2229.
Al Moustafa, A.E., Foulkes, W.D., Benlimame, N., et al., E6/E7 Proteins of HPV Type 16 and ErbB-2 Cooperate to Induce Neoplastic Transformation of Primary Normal Oral Epithelial Cells, Oncogene, 2004, vol. 23, no. 2, pp. 350–358.
Kusakari, T., Kariya, M., Mandai, M., et al., C-ErbB-2 or Mutant Ha-Ras Induced Malignant Transformation of Immortalized Human Ovarian Surface Epithelial Cells in vitro, Brit. J. Cancer, 2003, vol. 89, no. 12, pp. 2293–2298.
Ropiquet, F., Huguenin, S., Villette, J.M., et al., FGF7/KGF Triggers Cell Transformation and Invasion on Immortalised Human Prostatic Epithelial PNT1A Cells, Int. J. Cancer, 1999, vol. 82, no. 2, pp. 237–243.
Govindarajan, B., Shah, A., Cohen, C., et al., Malignant Transformation of Human Cells by Constitutive Expression of Platelet-Derived Growth Factor-BB, J. Biol. Chem., 2005, no. 14, pp. 13936–13943.
Gutkind, J.S., Novotny, E.A., Brann, M.R., and Robbins, K.C., Muscarinic Acetylcholine Receptor Subtypes as Agonist-Dependent Oncogenes, Proc. Nat. Acad. Sci. U.S.A., 1991, vol. 88, no. 11, pp. 4703–4707.
Sun, M., Wang, G., Paciga, J.E., et al., AKT1/PKBalpha Kinase Is Frequently Elevated in Human Cancers and Its Constitutive Activation Is Required for Oncogenic Transformation in NIH3T3 Cells, Am. J. Pathol., 2001, vol. 159, no. 2, pp. 431–437.
Keren-Paz, A., Bercovich, Z., Porat, Z., et al., Overexpression of Antizyme-Inhibitor in NIH3T3 Fibroblasts Provides Growth Advantage Through Neutralization of Antizyme Functions, Oncogene, 2006, vol. 25, no. 37, pp. 5163–5172.
Tao, W.J., Lin, H., Sun, T., et al., BCR-ABL Oncogenic Transformation of NIH 3T3 Fibroblasts Requires the IL-3 Receptor BCR-ABL Transformation of 3T3 Cells Requires IL-3R, Oncogene, 2008, vol. 27, no. 22, pp. 3194–3200.
Xiang-yong, L., Yang-chao, C., Ke-yuan, Z., et al., Overexpression of Bax Inhibitor-1 (BI-1) Induces Cell Transformation in NIH3T3 Cells, Cell. Biol. Int., 2010, vol. 34, no. 11, pp. 1099–1104.
Lin, R., Bagrodia, S., Cerione, R., and Manor, D., A Novel Cdc42Hs Mutant Induces Cellular Transformation, Curr. Biol., 1997, vol. 7, no. 10, pp. 794–797.
Moiola, C., De Luca, P., Gardner, K., et al., Cyclin T1 Overexpression Induces Malignant Transformation and Tumor Growth, Cell Cycle, 2010, vol. 9, no. 15, pp. 3119–3126.
Anand, N., Murthy, S., Amann, G., et al., Protein Elongation Factor EEF1A2 Is a Putative Oncogene in Ovarian Cancer, Nat. Genet., 2002, vol. 31, no. 3, pp. 301–305.
Greulich, H., Chen, T.H., Feng, W., et al., Oncogenic Transformation by Inhibitor-Sensitive and Resistant EGFR Mutants, PLoS Med., 2005, vol. 2, no. 11, p. e313.
Moscatelli, D. and Quarto, N., Transformation of NIH 3T3 Cells with Basic Fibroblast Growth Factor or the Hst/K-Fgf Oncogene Causes Downregulation of the Fibroblast Growth Factor Receptor: Reversal of Morphological Transformation and Restoration of Receptor Number by Suramin, J. Cell Biol., 1989, vol. 109, no. 5, pp. 2519–2527.
Fuller-Pace, F., Peters, G., and Dickson, C., Cell Transformation by KFGF Requires Secretion but Not Glycosylation, J. Cell Biol., 1991, vol. 115, no. 2, pp. 547–555.
Lawshe, A. Shankar, D.B., et al., FGF-8 Isoforms Differ in NIH3T3 Cell Transforming Potential, Cell Growth Differ., 1995, vol. 6, no. 7, pp. 817–825.
Hu, Y., Ying, H., and Xu, Y., HF-LANa, a Human Homologue of Derlin Family, Regulating the Expression of Cancer-Related Genes Promotes NIH3T3 Cell Transformation, Cancer Lett., 2007, vol. 258, no. 2, pp. 171–180.
De vivo, M., Chen, J., Codina, J., and Iyengar, R., Enhanced Phospholipase C Stimulation and Transformation in NIH-3T3 Cells Expressing Q209LGqalpha-Subunits, J. Biol. Chem., 1992, vol. 267, no. 26, pp. 18263–18266.
Kroll, S.D., Chen, J., De vivo, M., et al., The Q205LGo-Alpha Subunit Expressed in NIH-3T3 Cells Induces Transformation, J. Biol. Chem., 1992, no. 32, pp. 23183–23188.
Ram, P.T., Horvath, C.M., and Iyengar, R., Stat3-Mediated Transformation of NIH-3T3 Cells by the Constitutively Active Q205L Galphao Protein, Science, 2000, vol. 287, no. 5450, pp. 142–144.
Kuo, W., Lin, J., and Tang, T.K., Human Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Transforms NIH 3T3 Cells and Induces Tumors in Nude Mice, Int. J. Cancer, 2000, vol. 85, no. 6, pp. 857–864.
Ha, S.A., Shin, S.M., Lee, Y.J., et al., HCCRBP-1 Directly Interacting with HCCR-1 Induces Tumorigenesis Through P53 Stabilization, Int. J. Cancer, 2008, vol. 122, no. 3, pp. 501–508.
Gao, G., Peng, M., Zhu, L., et al., Human Papillomavirus 16 Variant E7 Gene Induces Transformation of NIH 3T3 Cells via Up-Regulation of Cdc25A and Cyclin A, Int. J. Gynecol. Cancer, 2009, vol. 19, no. 4, pp. 494–499.
Ryoo, Z.Y., Jung, B.K., Lee, S.R., et al., Neoplastic Transformation and Tumorigenesis Associated with Overexpression of IMUP-1 and IMUP-2 Genes in Cultured NIH/3T3 Mouse Fibroblasts, Biochem. Biophys. Res. Commun., 2006, vol. 349, no. 3, pp. 995–1002.
Caruana, G., Cambareri, A.C., Gonda, T.J., and Ashman, L.K., Transformation of NIH3T3 Fibroblasts by the C-Kit Receptor Tyrosine Kinase: Effect of Receptor Density and Ligand-Requirement, Oncogene, 1998, vol. 16, no. 2, pp. 179–190.
Viswanathan, S.R., Powers, J.T., Einhorn, W., et al., Lin28 Promotes Transformation and Is Associated with Advanced Human Malignancies, Nat. Genet., 2009, vol. 41, no. 7, pp. 843–848.
Fridman, R., Sweeney, T.M., Zain, M., et al., Malignant Transformation of NIH-3T3 Cells after Subcutaneous Co-Injection with a Reconstituted Basement Membrane (Matrigel), Int. J. Cancer, 1992, vol. 51, no. 5, pp. 740–754.
Kadomatsu, K., Hagihara, M., Akhter, S., et al., Midkine Induces the Transformation of NIH3T3 Cells, Brit. J. Cancer, 1997, vol. 75, no. 3, pp. 354–359.
Komiya, K., Sueoka-Aragane, N., Sato, A., et al., Mina53, a Novel c-myc Target Gene, Is Frequently Expressed in Lung Cancers and Exerts Oncogenic Property in NIH/3T3 Cells, J. Cancer Res. Clin. Oncol., 2010, vol. 136, no. 3, pp. 465–473.
Bafna, S., Singh, A.P., Moniaux, N., et al., MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells, Cancer Res., 2008, vol. 68, no. 22, pp. 9231–9238.
Piestun, D., Kochupurakkal, B.S., Jacob-Hirsch, J., et al., Nanog Transforms NIH3T3 Cells and Targets Cell-Type Restricted Genes, Biochem. Biophys. Res. Commun., 2006, vol. 343, no. 1, pp. 279–285.
Moshier, J.A., Dosescu, J., Skunca, M., and Luk, G.D., Transformation of NIH/3T3 Cells by Ornithine Decarboxylase Overexpression, Cancer Res., 1993, vol. 53, no. 11, pp. 2618–2622.
Moshier, J.A., Malecka-Panas, E., Geng, H., et al., Ornithine Decarboxylase Transformation of NIH/3T3 Cells Is Mediated by Altered Epidermal Growth Factor Receptor Activity, Cancer Res., 1995, vol. 55, no. 22, pp. 5358–5365.
Platica, M., Ivan, E., Ionescu, A., et al., Transformation of NIH 3T3 Cells by Enhanced PAR Expression, Biochem. Biophys. Res. Commun., 2004, vol. 314, no. 3, pp. 891–896.
Clarke, M.F. and Westin, E.H., Malignant Transformation of NIH 3T3 Fibroblasts by Human C-Sis Is Dependent Upon the Level of Oncogene Expression, Mol. Carcinog., 1992, vol. 5, no. 4, pp. 311–319.
Kim, H.R., Upadhyay, S., Korsmeyer, S., and Deuel, T.F., Platelet-Derived Growth Factor (PDGF) B and A Homodimers Transform Murine Fibroblasts Depending on the Genetic Background of the Cell, J. Biol. Chem., 1994, no. 48, pp. 30604–30608.
Chauhan, A.K., Li, Y.S., and Deuel, T.F., Pleiotrophin Transforms NIH 3T3 Cells and Induces Tumors in Nude Mice, Proc. Nat. Acad. Sci. U.S.A., 1993, vol. 90, no. 2, pp. 679–682.
Tabib, A. and Bachrach, U., Role of Polyamines in Mediating Malignant Transformation and Oncogene Expression, Int. J. Biochem. Cell Biol., 1999, vol. 31, no. 11, pp. 1289–1295.
Cranston, A., Carniti, C., Martin, S., et al., A Novel Activating Mutation in the RET Tyrosine Kinase Domain Mediates Neoplastic Transformation, Mol. Endocrinol., 2006, no. 7, pp. 1633–1643.
Shalloway, D., Johnson, P.J., Freed, E.O., et al., Transformation of NIH 3T3 Cells by Cotransfection with C-Src and Nuclear Oncogenes, Mol. Cell Biol., 1987, vol. 7, no. 10, pp. 3582–3590.
Shalloway, D., Coussens, P.M., and Yaciuk, P., Overexpression of the C-Src Protein Does Not Induce Transformation of NIH 3T3 Cells, Proc. Nat. Acad. Sci. U.S.A., 1984, vol. 81, no. 22, p. 7071.
Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., et al., Stat3 as an Oncogene, Cell, 1999, vol. 98, no. 3, pp. 295–303.
Radhakrishnan, V.M. and Martinez, J.D., 14-3-3gamma Induces Oncogenic Transformation by Stimulating MAP Kinase and PI3K Signaling, PLoS One, 2010, vol. 5, no. 7, p. e11433.
Wang, C., Lisanti, M.P., and Liao, D.J., Reviewing Once More the c-myc and ras Collaboration: Converging at the Cyclin D1-CDK4 Complex and Challenging Basic Concepts of Cancer Biology, Cell Cycle, 2011, vol. 10, no. 1, pp. 57–67.
Meloche, S. and Pouyssegur, J., The ERK1/2 Mitogen-Activated Protein Kinase Pathway as a Master Regulator of the G1- to S-Phase Transition, Oncogene, 2007, vol. 26, no. 22, pp. 3227–3239.
McCubrey, J.A., Steelman, L.S., Chappell, W.H., et al., Roles of the Raf/MEK/ERK Pathway in Cell Growth, Malignant Transformation and Drug Resistance, Biochim. Biophys. Acta, 2007, vol. 1773, no. 8, pp. 1263–1284.
Chambard, J.C., Lefloch, R., Pouyssegur, J., and Lenormand, P., ERK Implication in Cell Cycle Regulation, Biochim. Biophys. Acta, 2007, vol. 1773, no. 8, pp. 1299–1310.
Jiang, B.H. and Liu, L.Z., PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis, Adv. Cancer Res., 2009, vol. 102, pp. 19–65.
Donnell, K.A. Zeller, K.I., et al., The c-myc Target Gene Network, Semin. Cancer Biol., 2006, vol. 16, no. 4, pp. 253–264.
Rodriguez, J., Calvo, F., Gonzalez, J.M., et al., ERK1/2 MAP Kinases Promote Cell Cycle Entry by Rapid, Kinase-Independent Disruption of Retinoblastomalamin A Complexes, J. Cell Biol., 2010, vol. 191, no. 5, pp. 967–979.
Manning, B.D. and Cantley, L.C., AKT/PKB Signaling: Navigating Downstream, Cell, 2007, vol. 129, no. 7, pp. 1261–1274.
Rosner, M., Fuchs, C., Siegel, N., et al., Functional Interaction of Mammalian Target of Rapamycin Complexes in Regulating Mammalian Cell Size and Cell Cycle, Hum. Mol. Genet., 2009, vol. 18, no. 17, pp. 3298–3310.
Menon, S. and Manning, B.D., Common Corruption of the MTOR Signaling Network in Human Tumors, Oncogene, 2008, Suppl. 2, pp. S43–S51.
Zoncu, R., Efeyan, A., and Sabatini, D.M., MTOR: From Growth Signal Integration to Cancer, Diabetes and Ageing, Nat. Rev. Mol. Cell Biol., 2011, vol. 12, no. 1, pp. 21–35.
Winter, J.N., Jefferson, L.S., and Kimball, S.R., The ERK and Akt Signaling Pathways Function Through Parallel Mechanisms to Promote MTORC1, Amer. J. Physiol. Cell Physiol., 2011, no. 5, pp. 1172–1180.
Fingar, D.C., Richardson, C.J., Tee, A.R., et al., MTOR Controls Cell Cycle Progression Through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E, Mol. Cell. Biol., 2004, vol. 24, no. 1, pp. 200–216.
Dowling, R.J., Topisirovic, I., Alain, T., et al., MTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs, Science, 2010, vol. 328, no. 5982, pp. 1172–1176.
Tarn, W.Y. and Lai, M.C., Translational Control of Cyclins, Cell Div., 2011, vol. 6, no. 1.
Oyama, K., Okawa, T., Nakagawa, H., et al., AKT Induces Senescence in Primary Esophageal Epithelial Cells But Is Permissive for Differentiation as Revealed in Organotypic Culture, Oncogene, 2007, vol. 26, no. 16, pp. 2353–2364.
Nogueira, V., Park, Y., Chen, C.C., et al., Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis, Cancer Cell, 2008, vol. 14, no. 6, pp. 458–470.
Miyauchi, H., Minamino, T., Tateno, K., et al., Akt Negatively Regulates the in vitro Lifespan of Human Endothelial Cells via a P53/P21-Dependent Pathway, EMBO J., 2004, vol. 23, no. 1, pp. 212–220.
Minamino, T., Miyauchi, H., Tateno, K., et al., Akt-Induced Cellular Senescence: Implication for Human Disease, Cell Cycle, 2004, vol. 3, no. 4, pp. 449–451.
Besson, A. and Yong, V.W., Involvement of P21(Waf1/Cip1) in Protein Kinase C alpha-Induced Cell Cycle Progression, Mol. Cell Biol., 2000, vol. 20, no. 13, pp. 4580–4590.
Coleman, M.L., Marshall, C.J., and Olson, M.F., Ras Promotes P21(Waf1/Cip1) Protein Stability via a Cyclin D1-Imposed Block in Proteasome-Mediated Degradation, EMBO J., 2003, vol. 22, no. 9, pp. 2036–2046.
Ciccarelli, C., Marampon, F., Scoglio, A., et al., P21WAF1 Expression Induced by MEK/ERK Pathway Activation or Inhibition Correlates with Growth Arrest, Myogenic Differentiation and Onco-Phenotype Reversal in Rhabdomyosarcoma Cells, Mol. Cancer, 2005, vol. 4, no. 41.
Yang, X., Wang, W., Fan, J., et al., Prostaglandin A2-Mediated Stabilization of P21 MRNA Through an ERK-Dependent Pathway Requiring the RNA-Binding Protein HuR, J. Biol. Chem., 2004, vol. 279, no. 47, pp. 49298–49306.
Hu, T.H., Tai, M.H., Chuah, S.K., et al., Elevated P21 Expression Is Associated with Poor Prognosis of Rectal Stromal Tumors after Resection, J. Surg. Oncol., 2008, vol. 98, no. 2, pp. 117–123.
Takeshima, Y., Yamasaki, M., Nishisaka, T., et al., P21WAF1/CIP1 Expression in Primary Lung Adenocarcinomas: Heterogeneous Expression in Tumor Tissues and Correlation with P53 Expression and Proliferative Activities, Carcinogenesis, 1998, vol. 19, no. 10, pp. 1755–1761.
Korkolopoulou, P., Konstantinidou, A.E., Thomas-Tsagli, E., et al., WAF1/P21 Protein Expression Is an Independent Prognostic Indicator in Superficial and Invasive Bladder Cancer, Appl. Immun. Mol. Morphol., 2000, vol. 8, no. 4, pp. 285–292.
Abdulamir, A.S., Hafidh, R.R., Mahdi, L.K., et al., The Interplay between P53 and P21 Tumor Suppressor Proteins in the Transformation of Colorectal Adenoma to Carcinoma, Amer. J. Immunol., 2008, vol. 4, no. 2, pp. 14–22.
Kamiya, M. and Nakazato, Y., The Expression of P73, P21 and MDM2 Proteins in Gliomas, J. Neurooncol., 2002, no. 2, pp. 143–149.
Zhang, M.F., Zhang, Z.Y., Fu, J., et al., Correlation between Expression of P53, P21/WAF1, and MDM2 Proteins and Their Prognostic Significance in Primary Hepatocellular Carcinoma, J. Transl. Med., 2009, vol. 7, no. 110.
Mouriaux, F., Maurage, C.A., Labalette, P., et al., Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors, Invest. Ophthalmol. Vis. Sci., 2000, vol. 41, no. 10, pp. 2837–2843.
Peeper, D.S., Ras and PRb: The Relationship Gets Yet More Intimate, Cancer Cell, 2009, vol. 15, no. 4, pp. 243–245.
Slingerland, J. and Pagano, M., Regulation of the Cdk Inhibitor P27 and Its Deregulation in Cancer, J. Cell Physiol., 2000, vol. 183, no. 1, pp. 10–17.
Nicholson, J.M. and Duesberg, P., On the Karyotypic Origin and Evolution of Cancer Cells, Cancer Genet. Cytogenet., 2009, vol. 194, no. 2, pp. 96–110.
Klein, A., Li, N., Nicholson, J.M., McCormack, A.A., et al., Transgenic Oncogenes Induce Oncogene-Independent Cancers with Individual Karyotypes and Phenotypes, Cancer Genet. Cytogenet., 2010, vol. 200, no. 2, pp. 79–99.
Li, L., McCormack, A.A., Nicholson, J.M., et al., Cancer-Causing Karyotypes: Chromosomal Equilibria between Destabilizing Aneuploidy and Stabilizing Selection for Oncogenic Function, Cancer Genet. Cytogenet., 2009, vol. 188, no. 1, pp. 1–25.
Duesberg, P., Mandrioli, D., McCormack, A., and Nicholson, J.M., Is Carcinogenesis a Form of Speciation?, Cell Cycle, 2011, vol. 10, no. 13.
Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J., an Oncogene-Induced DNA Damage Model for Cancer Development, Science, 2008, vol. 319, no. 5868, pp. 1352–1355.
Bylund, L., Kytola, S., Lui, W.O., et al., Analysis of the Cytogenetic Stability of the Human Embryonal Kidney Cell Line 293 by Cytogenetic and STR Profiling Approaches, Cytogenet. Genome Res., 2004, vol. 106, no. 1, pp. 28–32.
Louis, N., Evelegh, C., and Graham, F.L., Cloning and Sequencing of the Cellular-Viral Junctions from the Human Adenovirus Type 5 Transformed 293 Cell Line, Virology, 1997, vol. 233, no. 2, pp. 423–429.
Zur Hausen, H., Induction of Specific Chromosomal Aberrations by Adenovirus Type 12 in Human Embryonic Kidney Cells, J. Virol., 1967, vol. 1, no. 6, pp. 1174–1185.
McDougall, J.K., Adenovirus-Induced Chromosome Aberrations in Human Cells, J. Gen. Virol., 1971, vol. 12, no. 1, pp. 43–51.
Kim, J.H., Choi, E.Y., Jung, E.-S., et al., Characterization of Clones of Human Cell Line Infected with Porcine Endogenous Retrovirus (PERV) from Porcine Cell Line, PK-15, Infect. Chemother., 2009, vol. 41, no. 1, pp. 1–8.
Shen, C., Gu, M., Song, C., et al., The Tumorigenicity Diversification in Human Embryonic Kidney 293 Cell Line Cultured in vitro, Biologicals, 2008, vol. 36, no. 4, pp. 263–268.
Rubin, A.L., Arnstein, P., and Rubin, H., Physiological Induction and Reversal of Focus Formation and Tumorigenicity in NIH 3T3 Cells, Proc. Nat. Acad. Sci. U.S.A., 1990, vol. 87, no. 24, pp. 10005–10009.
Rubin, A.L. and Ellison, B.J., Induction of Transformation in NIH3T3 Cells by Moderate Growth Constraint: Evidence That Neoplasia Is Driven by Adaptational Change, Carcinogenesis, 1991, no. 10, pp. 1801–1806.
Rubin, H., Cellular Epigenetics: Effects of Passage History on Competence of Cells for “Spontaneous” Transformation, Proc. Nat. Acad. Sci. U.S.A., 1993, vol. 90, no. 22, pp. 10715–10719.
Rubin, H., The Role of Selection in Progressive Neoplastic Transformation, Adv. Cancer Res., 2001, vol. 83, pp. 159–207.
Rubin, H., Multistage Carcinogenesis in Cell Culture, Dev. Biol. (Basel), 2001, vol. 106, pp. 61–66.
Rubin, H., Cell-Cell Contact Interactions Conditionally Determine Suppression and Selection of the Neoplastic Phenotype, Proc. Nat. Acad. Sci. U.S.A., 2008, vol. 105, no. 17, pp. 6215–6221.
Millau, J.F., Mai, S., Bastien, N., and Drouin, R., P53 Functions and Cell Lines: Have We Learned the Lessons from the Past?, BioEssays, 2010, vol. 32, no. 5, pp. 392–400.
Nielsen, K.V. and Briand, P., Cytogenetic Analysis of in vitro Karyotype Evolution in a Cell Line Established from Nonmalignant Human Mammary Epithelium, Cancer Genet. Cytogenet., 1989, vol. 39, no. 1, pp. 103–118.
Bartholdi, M.F., Ray, F.A., Cram, L.S., and Kraemer, P.M., Karyotype Instability of Chinese Hamster Cells during in vivo Tumor Progression, Somat. Cell. Mol. Genet., 1987, vol. 13, no. 1, pp. 1–10.
Duesberg, P. and Rasnick, D., Aneuploidy, the Somatic Mutation That Makes Cancer a Species of Its Own, Cell Motil. Cytoskeleton, 2000, vol. 47, no. 2, pp. 81–107.
Thorgeirsson, U.P., Turpeenniemi-Hujanen, T., Williams, J.E., et al., NIH/3T3 Cells Transfected with Human Tumor DNA Containing Activated Ras Oncogenes Express the Metastatic Phenotype in Nude Mice, Mol. Cell. Biol., 1985, vol. 5, no. 1, pp. 259–262.
Kuzumaki, N., Ogiso, Y., Oda, A., et al., Resistance to Oncogenic Transformation in Revertant R1 of Human Ras-Transformed NIH 3T3 Cells, Mol. Cell. Biol., 1989, vol. 9, no. 5, pp. 2258–2263.
Li, Y., Weibing, S., Liu, H., et al., Mitochondrial DNA from Colorectal Cancer Cells Promotes the Malignant Phenotype of NIH3T3 Cells, Cell Biol. Int., 2008, vol. 32, no. 8, pp. 979–983.
Zhang, K., Sun, J., Liu, N., et al., Transformation of NIH 3T3 Cells by HER3 or HER4 Receptors Requires the Presence of HER1 or HER2, J. Biol. Chem., 1996, vol. 271, no. 7, pp. 3884–3890.
Kadota, M., Yang, H.H., Gomez, B., et al., Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines, PLoS One, 2010, vol. 5, no. 2, p. e9201.
Zhang, D.L., Ji, L., Li, L.J., and Huang, G.S., Systematically Experimental Investigation on Carcinogenesis or Tumorigenicity of VERO Cell Lines of Different Karyotypes in Nude Mice in vivo Used for Viral Vaccine Manufacture, Acta Genet. Sin., 2004, vol. 31, no. 7, pp. 647–660.
Ragel, B.T., Couldwell, W.T., Gillespie, D.L., et al., A Comparison of the Cell Lines Used in Meningioma Research, Surg. Neurol., 2008, vol. 70, no. 3, pp. 295–307.
Thompson, S.L. and Compton, D.A., Examining the Link between Chromosomal Instability and Aneuploidy in Human Cells, J. Cell Biol., 2008, vol. 180, no. 4, pp. 665–672.
Roschke, A.V., Tonon, G., Gehlhaus, K.S., et al., Karyotypic Complexity of the NCI-60 Drug-Screening Panel, Cancer Res., 2003, vol. 63, no. 24, pp. 8634–8647.
Bussey, K.J., Chin, K., Lababidi, S., et al., Integrating Data on DNA Copy Number with Gene Expression Levels and Drug Sensitivities in the NCI-60 Cell Line Panel, Mol. Cancer Ther., 2006, vol. 5, no. 4, pp. 853–867.
Lundberg, E., Fagerberg, L., Klevebring, D., et al., Defining the Transcriptome and Proteome in Three Functionally Different Human Cell Lines, Mol. Syst. Biol., 2010, vol. 6, no. 450.
Valsesia, A., Rimoldi, D., Martinet, D., et al., Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic Melanoma, PLoS One, 2011, vol. 6, no. 4, p. e18369.
Geiger, T., Cox, J., and Mann, M., Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells, PLoS Genet, 2010, vol. 6, no. 9, p. e1001090.
Pavelka, N., Rancati, G., Zhu, J., et al., Aneuploidy Confers Quantitative Proteome Changes and Phenotypic Variation in Budding Yeast, Nature, 2010, vol. 468, no. 7321, pp. 321–325.
Bajaj, R., Xu, F., Xiang, B., et al., Evidence-Based Genomic Diagnosis Characterized Chromosomal and Cryptic Imbalances in 30 Elderly Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia, Mol. Cytogenet., 2011, no. 3, p. 4.
Hurst, C.D., Fiegler, H., Carr, P., et al., High-Resolution Analysis of Genomic Copy Number Alterations in Bladder Cancer by Microarray-Based Comparative Genomic Hybridization, Oncogene, 2004, vol. 23, no. 12, pp. 2250–2263.
Qin, S.L., Chen, X.J., Xu, X., et al., Detection of Chromosomal Alterations in Bladder Transitional Cell Carcinomas from Northern China by Comparative Genomic Hybridization, Cancer Lett., 2006, vol. 238, no. 2, pp. 230–239.
Prat, E., del Rey, J., Ponsa, I., et al., Comparative Genomic Hybridization Analysis Reveals New Different Subgroups in Early-Stage Bladder Tumors, Urology, 2010, vol. 75, no. 2, pp. 347–355.
Nikolsky, Y., Sviridov, E., Yao, J., et al., Genomewide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer, Cancer Res., 2008, no. 22, pp. 9532–9540.
Stephens, P.J., McBride, D.J., Lin, M.L., et al., Complex Landscapes of Somatic Rearrangement in Human Breast Cancer Genomes, Nature, 2009, vol. 462, no. 7276, pp. 1005–1010.
Russnes, H.G., Vollan, H.K., Lingjaerde, O.C., et al., Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients, Sci. Transl. Med., 2010, no. 38, pp. 38–47.
Smid, M., Hoes, M., Sieuwerts, A.M., et al., Patterns and Incidence of Chromosomal Instability and Their Prognostic Relevance in Breast Cancer Subtypes, Breast Cancer Res. Treat., 2011, vol. 128, no. 1, pp. 23–30.
Navin, N., Krasnitz, A., Rodgers, L., et al., Inferring Tumor Progression from Genomic Heterogeneity, Genome Res., 2010, vol. 20, no. 1, pp. 68–80.
Heselmeyer, K., Macville, M., Schrock, E., et al., Advanced-Stage Cervical Carcinomas Are Defined by a Recurrent Pattern of Chromosomal Aberrations Revealing High Genetic Instability and a Consistent Gain of Chromosome Arm 3q, Genes Chromosomes Cancer., 1997, vol. 19, no. 4, pp. 233–240.
Kloth, J.N., Oosting, J., van Wezel, T., et al., Combined Array-Comparative Genomic Hybridization and Single-Nucleotide Polymorphism-Loss of Heterozygosity Analysis Reveals Complex Genetic Alterations in Cervical Cancer, BMC Genom., 2007, vol. 8, no. 53.
He, Q.J., Zeng, W.F., Sham, J.S., et al., Recurrent Genetic Alterations in 26 Colorectal Carcinomas and 21 Adenomas from Chinese Patients, Cancer Genet. Cytogenet., 2003, vol. 144, no. 2, pp. 112–118.
Gaasenbeek, M., Howarth, K., Rowan, A.J., et al., Combined Array-Comparative Genomic Hybridization and Single-Nucleotide Polymorphism-Loss of Heterozygosity Analysis Reveals Complex Changes and Multiple Forms of Chromosomal Instability in Colorectal Cancers, Cancer Res., 2006, vol. 66, no. 7, pp. 3471–3479.
Xiao, X.Y., Zhou, X.Y., Yan, G., et al., Chromosomal Alteration in Chinese Sporadic Colorectal Carcinomas Detected by Comparative Genomic Hybridization, Diagn. Mol. Pathol., 2007, vol. 16, no. 2, pp. 96–103.
Castorina, S., Barresi, V., Luca, T., et al., Recent Advances in Molecular Diagnostics of Colorectal Cancer by Genomic Arrays: Proposal for a Procedural Shift in Biological Sampling and Pathological Report, Ital. J. Anat. Embryol., 2010, vol. 115, nos. 1/2, pp. 39–45.
Micci, F., Teixeira, M.R., Haugom, L., et al., Genomic Aberrations in Carcinomas of the Uterine Corpus, Genes Chromosomes Cancer., 2004, vol. 40, no. 3, pp. 229–246.
Shing, D.C., Morley-Jacob, C.A., Roberts, I., et al., Ewing’s Tumour: Novel Recurrent Chromosomal Abnormalities Demonstrated by Molecular Cytogenetic Analysis of Seven Cell Lines and One Primary Culture, Cytogenet. Genome Res., 2002, vol. 97, nos. 1/2, pp. 20–27.
Takada, H., Imoto, I., Tsuda, H., et al., Screening of DNA Copy-Number Aberrations in Gastric Cancer Cell Lines by Array-Based Comparative Genomic Hybridization, Cancer Sci., 2005, vol. 96, no. 2, pp. 100–110.
Veltman, I., Veltman, J., Janssen, I., et al., Identification of Recurrent Chromosomal Aberrations in Germ Cell Tumors of Neonates and Infants Using Genome-Wide Array-Based Comparative Genomic Hybridization, Genes Chromosomes Cancer., 2005, vol. 43, no. 4, pp. 367–376.
Kim, D.H., Mohapatra, G., Bollen, A., et al., Chromosomal Abnormalities in Glioblastoma Multiforme Tumors and Glioma Cell Lines Detected by Comparative Genomic Hybridization, Int. J. Cancer, 1995, vol. 60, no. 6, pp. 812–819.
Inda, M.M., Fan, X., Munoz, J., et al., Chromosomal Abnormalities in Human Glioblastomas: Gain in Chromosome 7p Correlating with Loss in Chromosome 10q, Mol. Carcinog., 2003, vol. 36, no. 1, pp. 6–14.
Roversi, G., Pfundt, R., Moroni, R.F., et al., Identification of Novel Genomic Markers Related to Progression to Glioblastoma Through Genomic Profiling of 25 Primary Glioma Cell Lines, Oncogene, 2006, vol. 25, no. 10, pp. 1571–1583.
Vranova, V., Necesalova, E., Kuglik, P., et al., Screening of Genomic Imbalances in Glioblastoma Multiforme Using High-Resolution Comparative Genomic Hybridization, Oncol. Rep., 2007, vol. 17, no. 2, pp. 457–464.
Gardina, P.J., Lo, K.C., Lee, W., et al., Ploidy Status and Copy Number Aberrations in Primary Glioblastomas Defined by Integrated Analysis of Allelic Ratios, Signal Ratios and Loss of Heterozygosity Using 500 K SNP Mapping Arrays, BMC Genom., 2008, vol. 9, no. 489.
Lo, K.C., Bailey, D., Burkhardt, T., et al., Comprehensive Analysis of Loss of Heterozygosity Events in Glioblastoma Using the 100K SNP Mapping Arrays and Comparison with Copy Number Abnormalities Defined by BAC Array Comparative Genomic Hybridization, Genes Chromosomes Cancer., 2008, vol. 47, no. 3, pp. 221–227.
Dahlback, H.S., Brandal, P., Meling, T.R., et al., Genomic Aberrations in 80 Cases of Primary Glioblastoma Multiforme: Pathogenetic Heterogeneity and Putative Cytogenetic Pathways, Genes Chromosomes Cancer., 2009, vol. 48, no. 10, pp. 908–924.
Speicher, M.R., Howe, C., Crotty, P., et al., Comparative Genomic Hybridization Detects Novel Deletions and Amplifications in Head and Neck Squamous Cell Carcinomas, Cancer Res., 1995, vol. 55, no. 5, pp. 1010–1013.
Bockmuhl, U., Schwendel, A., Dietel, M., and Petersen, I., Distinct Patterns of Chromosomal Alterations in High- and Low-Grade Head and Neck Squamous Cell Carcinomas, Cancer Res., 1996, vol. 56, no. 23, pp. 5325–5329.
Campbell, P.J., Stephens, P.J., Pleasance, E.D., et al., Identification of Somatically Acquired Rearrangements in Cancer Using Genome-Wide Massively Parallel Paired-End Sequencing, Nat. Genet., 2008, vol. 40, no. 6, pp. 722–729.
Belloni, E., Veronesi, G., Micucci, C., et al., Genomic Characterization of Asymptomatic CT-Detected Lung Cancers, Oncogene, 2011, vol. 30, no. 9, pp. 1117–1126.
Tiu, R.V., Gondek, L.P., O’Keefe, C.L., et al., Prognostic Impact of SNP Array Karyotyping in Myelodysplastic Syndromes and Related Myeloid Malignancies, Blood, 2011, vol. 117, no. 17, pp. 4552–4560.
Ambatipudi, S., Gerstung, M., Gowda, R., et al., Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome, PLoS One, 2011, vol. 6, no. 2, p. e17250.
Welkoborsky, H.J., Bernauer, H.S., Riazimand, H.S., et al., Patterns of Chromosomal Aberrations in Metastasizing and Nonmetastasizing Squamous Cell Carcinomas of the Oropharynx and Hypopharynx, Ann. Otol. Rhinol. Laryngol., 2000, vol. 109, no. 4, pp. 401–410.
Hauptmann, S., Denkert, C., Koch, I., et al., Genetic Alterations in Epithelial Ovarian Tumors Analyzed by Comparative Genomic Hybridization, Hum. Pathol., 2002, vol. 33, no. 6, pp. 632–641.
Mahlamaki, E.H., Hoglund, M., Gorunova, L., et al., Comparative Genomic Hybridization Reveals Frequent Gains of 20q, 8q, 11q, 12p, and 17q, and Losses of 18q, 9p, and 15q in Pancreatic Cancer, Genes Chromosomes Cancer., 1997, vol. 20, no. 4, pp. 383–391.
Campbell, P.J., Yachida, S., Mudie, L.J., et al., The Patterns and Dynamics of Genomic Instability in Metastatic Pancreatic Cancer, Nature, 2010, vol. 467, no. 7319, pp. 1109–1113.
Berger, M.F., Lawrence, M.S., Demichelis, F., et al., The Genomic Complexity of Primary Human Prostate Cancer, Nature, 2011, vol. 470, no. 7333, pp. 214–220.
Wada, N., Duh, Q.Y., Miura, D., et al., Chromosomal Aberrations by Comparative Genomic Hybridization in Hurthle Cell Thyroid Carcinomas Are Associated with Tumor Recurrence, J. Clin. Endocrinol. Metab., 2002, vol. 87, no. 10, pp. 4595–4601.
Mattison, J., Kool, J., Uren, A.G., et al., Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach, Cancer Res., 2010, vol. 70, no. 3, pp. 883–895.
Beroukhim, R., Mermel, C.H., Porter, D., et al., The Landscape of Somatic Copy-Number Alteration across Human Cancers, Nature, 2010, vol. 463, no. 7283, pp. 899–905.
Nobusawa, S., Lachuer, J., Wierinckx, A., et al., Intratumoral Patterns of Genomic Imbalance in Glioblastomas, Brain Pathol., 2010, vol. 20, no. 5, pp. 936–944.
Tyson, J., Majerus, T.M., Walker, S., and Armour, J.A., Screening for Common Copy-Number Variants in Cancer Genes, Cancer Genet. Cytogenet., 2010, vol. 203, no. 2, pp. 316–323.
Fox, E.J., Salk, J.J., and Loeb, L.A., Cancer Genome Sequencing an Interim Analysis, Cancer Res., 2009, vol. 69, no. 12, pp. 4948–4950.
Gerlinger, M. and Swanton, C., How Darwinian Models Inform Therapeutic Failure Initiated by Clonal Heterogeneity in Cancer Medicine, Brit. J. Cancer, 2010, vol. 103, no. 8, pp. 1139–1143.
Swanton, C., Burrell, R.A., and Futreal, P.A., Breast Cancer Genome Heterogeneity: A Challenge to Personalized Medicine?, Breast Cancer Res., 2011, vol. 13, no. 1, p. 104.
Duesberg, P., Li, R., Sachs, R., et al., Cancer Drug Resistance: The Central Role of the Karyotype, Drug Resist. Updat., 2007, vol. 10, nos. 1–2, pp. 51–58.
Monni, O., Joensuu, H., Franssila, K., and Knuutila, S., DNA Copy Number Changes in Diffuse Large B-Cell Lymphoma Comparative Genomic Hybridization Study, Blood, 1996, vol. 87, no. 12, pp. 5269–5278.
Frank, C.J., McClatchey, K.D., Devaney, K.O., and Carey, T.E., Evidence That Loss of Chromosome 18q Is Associated with Tumor Progression, Cancer Res., 1997, vol. 57, no. 5, pp. 824–827.
Rickert, C.H., Dockhorn-Dworniczak, B., Busch, G., et al., Increased Chromosomal Imbalances in Recurrent Pituitary Adenomas, Acta Neuropathol., 2001, vol. 102, no. 6, pp. 615–620.
Nishio, J., Iwasaki, H., Ishiguro, M., et al., Synovial Sarcoma with a Secondary Chromosome Change Der(22)T(17;22)(Q12;Q12), Cancer Genet. Cytogenet., 2002, vol. 137, no. 1, pp. 23–28.
Gomori, E., Fulop, Z., Meszaros, I., et al., Microsatellite Analysis of Primary and Recurrent Glial Tumors Suggests Different Modalities of Clonal Evolution of Tumor Cells, J. Neuropathol. Exp. Neurol., 2002, vol. 61, no. 5, pp. 396–402.
Waldman, F.M., DeVries, S., Chew, K.L., et al., Chromosomal Alterations in Ductal Carcinomas in Situ and Their in Situ Recurrences, J. Natl. Cancer Inst., 2000, vol. 92, no. 4, pp. 313–320.
Ness, G.O., Lybaek, H., Arnes, J., and Rodahl, E., Chromosomal Imbalances in a Recurrent Solitary Fibrous Tumor of the Orbit, Cancer Genet. Cytogenet., 2005, vol. 162, no. 1, pp. 38–44.
Heinrich, U.R., Brieger, J., Gosepath, J., et al., Frequent Chromosomal Gains in Recurrent Juvenile Nasopharyngeal Angiofibroma, Cancer Genet. Cytogenet., 2007, no. 2, pp. 138–143.
Korshunov, A., Benner, A., Remke, M., et al., Accumulation of Genomic Aberrations during Clinical Progression of Medulloblastoma, Acta Neuropathol., 2008, vol. 116, no. 4, pp. 383–390.
Zieger, K., Wiuf, C., Jensen, K.M., et al., Chromosomal Imbalance in the Progression of High-Risk Nonmuscle Invasive Bladder Cancer, BMC Cancer, 2009, vol. 9, no. 149.
Cimini, D. and Degrassi, F., Aneuploidy: A Matter of Bad Connections, Trends Cell. Biol., 2005, vol. 15, no. 8, pp. 442–451.
Li, J.J. and Li, S.A., Mitotic Kinases: The Key to Duplication, Segregation, and Cytokinesis Errors, Chromosomal Instability, and Oncogenesis, Pharmacol. Ther., 2006, vol. 111, no. 3, pp. 974–984.
Cimini, D., Merotelic Kinetochore Orientation, Aneuploidy, and Cancer, Biochim. Biophys. Acta, 2008, vol. 1786, no. 1, pp. 32–40.
Holland, A.J. and Cleveland, D.W., Boveri Revisited: Chromosomal Instability, Aneuploidy and Tumorigenesis, Nat. Rev. Mol. Cell. Biol., 2009, vol. 10, no. 7, pp. 478–487.
McClelland, S.E., Burrell, R.A., and Swanton, C., Chromosomal Instability: A Composite Phenotype That Influences Sensitivity to Chemotherapy, Cell Cycle, 2009, vol. 8, no. 20, pp. 3262–3266.
Chandhok, N.S. and Pellman, D., A Little CIN May Cost a Lot: Revisiting Aneuploidy and Cancer, Curr. Opin. Genet. Dev., 2009, vol. 19, no. 1, pp. 74–81.
Rao, C.V., Yamada, H.Y., Yao, Y., and Dai, W., Enhanced Genomic Instabilities Caused by Deregulated Microtubule Dynamics and Chromosome Segregation: A Perspective from Genetic Studies in Mice, Carcinogenesis, 2009, vol. 30, no. 9, pp. 1469–1474.
Dillon, L.W., Burrow, A.A., and Wang, Y.H., DNA Instability at Chromosomal Fragile Sites in Cancer, Curr. Genom., 2010, vol. 11, no. 5, pp. 326–337.
Ting, D.T., Lipson, D., Paul, S., et al., Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers, Science, 2011, vol. 331, no. 6017, pp. 593–596.
Krajcovic, M., Johnson, N.B., Sun, Q., et al., A Nongenetic Route to Aneuploidy in Human Cancers, Nat. Cell. Biol., 2011, vol. 13, no. 3, pp. 324–330.
Kitada, K., Taima, A., Ogasawara, K., et al., Chromosome-Specific Segmentation Revealed by Structural Analysis of Individually Isolated Chromosomes, Genes Chromosomes Cancer., 2011, vol. 50, no. 4, pp. 217–227.
Tubio, J.M. and Estivill, X., Cancer: When Catastrophe Strikes a Cell, Nature, 2011, vol. 470, no. 7335, pp. 476–477.
Parsons, D.W., Li, M., Zhang, X., et al., The Genetic Landscape of the Childhood Cancer Medulloblastoma, Science, 2011, vol. 331, no. 6016, pp. 435–439.
Kan, Z., Jaiswal, B.S., Stinson, J., et al., Diverse Somatic Mutation Patterns and Pathway Alterations in Human Cancers, Nature, 2010, vol. 466, no. 7308, pp. 869–873.
Pleasance, E.D., Cheetham, R.K., Stephens, P.J., et al., A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome, Nature, 2010, vol. 463, no. 7278, pp. 191–196.
Sharma, S.V. and Settleman, J., Oncogene Addiction: Setting the Stage for Molecularly Targeted Cancer Therapy, Genes Dev., 2007, vol. 21, no. 24, pp. 3214–3231.
Heng, H.H., Cancer Genome Sequencing: The Challenges Ahead, BioEssays, 2007, no. 8, pp. 783–794.
Duesberg, P., Li, R., Fabarius, A., and Hehlmann, R., The Chromosomal Basis of Cancer, Cell Oncol., 2005, vol. 27, nos 5–6, pp. 293–318.
Lee, A.J., Endesfelder, D., Rowan, A.J., et al., Chromosomal Instability Confers Intrinsic Multidrug Resistance, Cancer Res., 2011, vol. 71, no. 5, pp. 1858–1870.
Marusyk, A. and Kornelia, P., Tumor Heterogeneity: Causes and Consequences, Biochim. Biophys. Acta, 2010, vol. 1805, no. 1, pp. 105–117.
Navin, N., Kendall, J., Troge, J., et al., Tumour Evolution Inferred by Single Cell Sequencing, Nature, 2011, vol. 472, no. 7341, pp. 90–94.
Navin, N. and Hicks, J., Future Medical Applications of Single Cell Sequencing in Cancer, Genome Med., 2011, vol. 3, no. 51.
Heng, H.H., Liu, G., Stevens, J.B., et al., Decoding the Genome Beyond Sequencing: The New Phase of Genomic Research, Genomics, 2011. doi: 10.1016/j.ygeno.2011.05.008
Heng, H.H., Stevens, J.B., Bremer, S.W., et al., The Evolutionary Mechanism of Cancer, J. Cell Biochem., 2010, vol. 109, no. 6, pp. 1072–1084.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
About this article
Cite this article
Stepanenko, A.A., Kavsan, V.M. Immortalization and malignant transformation of Eukaryotic cells. Cytol. Genet. 46, 96–129 (2012). https://doi.org/10.3103/S0095452712020041
Received:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0095452712020041